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Abstract I 
Abstract 
 
Dihydrodipicolinate synthase (DHDPS, E.C. 4.2.1.52) is the enzyme that catalyses the 
first committed step in the lysine biosynthetic pathway, which involves the condensation 
reaction between (S)-aspartate β-semialdehyde ((S)-ASA) and pyruvate via a ping-pong 
mechanism, and is feedback inhibited by lysine. The major hallmark of this reaction is 
the formation of a Schiff base intermediate between pyruvate and the active site residue 
lysine 161. Surprisingly, this had never been confirmed using site-directed mutagenesis. 
In an attempt to investigate the necessity of this residue, two site-directed mutants were 
generated: DHDPS-K161A and DHDPS-K161R. They were then over-expressed, 
purified and characterised by steady-state kinetics, circular dichroism (CD) spectroscopy, 
differential scanning fluorimetry (DSF), isothermal titration calorimetry (ITC) and X-ray 
crystallography. Wild-type DHDPS was also over-expressed, purified and characterised 
in order to provide baseline data for comparison. 
 
Unexpectedly, the mutant enzymes were still catalytically active, despite a significant 
decrease in activity. The kcat values for DHDPS-K161A and DHDPS-K161R were 
0.06±0.02 s-1 and 0.16±0.06 s-1 respectively, compared to 45±3 s-1 for the wild-type 
enzyme. Another interesting finding was a shift in the mechanism, from ping-pong to 
ternary-complex. This implies that the strict order of reaction sequences observed in the 
wild-type enzyme was relaxed in the mutant enzymes. The Km values with respect to 
pyruvate increased by only 3-fold for both enzymes (0.45±0.04 mM for DHDPS-K161A 
and 0.57±0.06 mM for DHDPS-K161R, compared to 0.15±0.01 mM for the wild-type 
DHDPS), indicating a subtle change in pyruvate binding affinity; while the KmASA value 
remained the same for DHDPS-K161R (0.12±0.01 mM) and increased by 2-fold for 
DHDPS-K161A (0.23±0.02 mM). Both enzymes behaved in an entirely analogous 
fashion to the wild-type enzyme in regards to lysine inhibition, demonstrating the lack of 
involvement of lysine 161 in the regulatory mechanism.   
 
Abstract II 
Treatment with
 
the reducing agent
 
sodium borohydride provided evidence that a Schiff 
base is not formed when pyruvate binds to either one of the mutant enzymes. DSF 
showed that the melting temperature for DHDPS-K161A and DHDPS-K161R upon 
addition of pyruvate increased to a lesser extent than for the wild-type enzyme, 
suggesting that stabilisation of DHDPS by pyruvate is largely dependent on Schiff base 
formation. 
 
CD spectroscopy showed that the mutant enzymes had identical secondary structures in 
solution to the wild-type enzyme. The crystal structures of DHDPS-K161A and DHDPS-
K161R were also solved to resolutions of 2.0 and 2.4 Å respectively. They showed no 
major rearrangement within their active sites, indicating that their attenuated catalytic 
activities were due to the removal of lysine 161, as opposed to gross structural alterations 
induced by the mutations. The crystal structure of the mutant enzymes were also solved 
with pyruvate bound and they showed that both mutant enzymes still had a well defined 
binding pocket for pyruvate that is not dependent of lysine 161. ITC experiments 
demonstrated that in the absence of Schiff base formation, entropic contributions may be 
responsible for the observed enzymatically accelerated reaction of the two DHDPS 
substrates, since no discernible heat was produced upon binding of pyruvate to the mutant 
enzymes.  
 
Based on these results, it can be concluded that although lysine 161 is important in the 
DHDPS-catalysed reaction, it is not absolutely essential. The current proposed 
mechanism, where the tautomerisation of the Schiff base to an enamine species creates 
the nucleophile necessary for attack of (S)-ASA, had to be reconsidered and expanded. 
We propose that the enol form of pyruvate, which exists in equilibrium with its keto 
tautomer, can fulfill the role of the enamine species. NMR studies using hydrogen-
deuterium exchange suggest that the rate of enolisation is unchanged in DHDPS-K161A 
and DHDPS-K161R catalysed mechanism, ruling out the possibility that the enolisation 
process could be the rate-determining step. It is likely that substrate orientation and 
favourable charge interactions may facilitate the interaction of an active site bound 
pyruvate with (S)-ASA and may be the major catalytic devices operating in DHDPS-
Abstract III 
K161A and DHDPS-K161R. Removal of the Schiff base-forming residue in DHDPS 
could not impede catalysis completely because of the existence of this ‘back-up’ 
mechanism, in which lysine 161 plays no part. These conclusions may shed light into the 
mechanism and evolution of enzymatic activity of other class I aldolases and they 
underscore the functional plasticity of enzyme active sites. 
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Chapter One 
 
Introduction 
 
 
 
The subject of this thesis is the enzyme dihydrodipicolinate synthase (DHDPS) from 
Escherichia coli. This enzyme catalyses the first committed step of the diaminopimelate 
pathway of lysine biosynthesis in plants and bacteria, and is feedback inhibited by the end 
product, lysine. 
 
The work described in this thesis focuses specifically on the elucidation of the role of an 
active site residue in this enzyme, lysine 161. This is achieved using site-directed 
mutagenesis, followed by characterisation of the variant forms of the enzyme using 
steady-state kinetics, far-ultraviolet (UV) circular dichroism (CD) spectroscopy, 
differential scanning fluorimetry (DSF), isothermal titration calorimetry (ITC), and X-ray 
crystallography. 
 
 
1.1  Background  
 
The identification of the novel amino acid, meso-diaminopimelate (DAP), found in 
bacterial hydrolysates1,2 led to the investigation of the bacterial biosynthetic pathway of 
lysine.3 This included the discovery of the enzyme that catalyses the first unique step in 
this pathway, DHDPS.4,5 
 
Lysine is an essential amino acid and is part of the aspartate family, which also includes 
methionine, threonine, and isoleucine.6,7 The biosynthesis of aspartate-derived amino 
acids is restricted to bacteria, plants and some fungi and, as such, they are essential amino 
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acids in animal nutrition.8 Lysine is often the most limiting amino acid nutritionally.9 
Thus, this pathway has been the focus of research for several years, much of which is 
ultimately aimed at the improvement of crop growth as well as enhancement of lysine 
production in crops.7,9 In addition, a branch of research has focused on the inhibition of 
DHDPS, which is a validated drug target10-12 because it occurs at a branchpoint in the 
lysine biosynthetic pathway and its inhibition has the potential to create novel herbicides 
and antibiotics.6,13 Neither area has yet met with much success, in part because the 
catalytic and regulatory mechanisms of the enzyme are not fully understood. 
 
 
1.2  Biosynthesis of the aspartate family of amino acids 
 
The first step in the synthesis of aspartate-derived amino acids involves the 
phosphorylation of (S)-aspartate to (S)-β-aspartyl phosphate, with subsequent reduction to 
(S)-aspartate β-semialdehyde ((S)-ASA) in an NADPH-dependent reaction (Figure 1.1). 
(S)-ASA resides at the branchpoint of the biosynthetic pathways of the four aspartate-
derived amino acids, as it either enters the diaminopimelate (DAP) pathway to produce 
(S)-lysine, or is reduced by homoserine dehydrogenase to give (S)-homoserine, the 
precursor to (S)-methionine, (S)-threonine, and (S)-isoleucine.6,14 
 
 
1.3 Dihydrodipicolinate synthase 
1.3.1 Genetic studies 
The dapA locus in E. coli, which encodes for DHDPS, was mapped to 53 minutes on the 
E. coli chromosome,15 cloned16 and sequenced.15 Based on the nucleotide sequence, a 
subunit molecular weight of 31,372 Da was deduced for the E. coli DHDPS. Unlike six 
of the nine enzymes present in the lysine biosynthetic pathway, the intracellular levels of 
DHDPS are not regulated at the genetic level by (S)-lysine.17  The dapA gene has also 
been cloned and sequenced from a number of other bacterial18-21 and plant sources.22-26 
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Figure 1.1 Biosynthesis of the aspartate family of amino acids.27 
 
 
1.3.2 Structural studies of E. coli DHDPS 
The crystal structure of E. coli DHDPS was first determined by Mirwaldt et al. (1995) at 
a resolution of 2.5 Å, but it has been refined since to a resolution of 1.9 Å (Figure 1.2).28 
The enzyme is homotetrameric, consisting of a dimer of tight dimers with weak contacts 
between the two tight dimers compared to the intradimeric contacts.29 Each monomer 
contains two domains: the N-terminal domain consists of residues 1 to 224 and folds into 
a (β/α)8 barrel, which contains the active site; the C-terminal domain consists of residues 
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224 to 292, forming three α-helices, the role of which remains to be resolved.30  This is a 
similar structure to other class I aldolases including N-acetylneuraminate lyase (NAL), 
which is mechanistically related to DHDPS.31 
 
 
Figure 1.2 The tetrameric structure of E. coli DHDPS, showing the four monomers 
labelled A-D. Monomers A/C and B/D associate tightly to form tight dimers, which self-
associate to form a tetramer.28 β-Sheets are coloured purple and α-helices are coloured 
cyan. The active sites are indicated by the black circles and the lysine binding sites are 
indicated by the red circles. This figure was produced using PyMol.32  
 
 
The active site 
E. coli DHDPS has four complete active sites. Based on the X-ray crystal structure of the 
E. coli enzyme29,30 and sequence homologies from DHDPS of other sources,33 it was 
proposed that a catalytic triad made up of residues Y133, T44 and Y107 is involved in 
A 
B 
C 
D 
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relaying protons in and out of the active site.27 This was confirmed by site-directed 
mutagenesis experiments, where the mutation of Y133 and Y107 to a phenylalanine and 
the mutation of T44 to a valine, resulted in enzymes that had substantially reduced 
catalytic activities.27 K161, which is the pyruvate binding residue, defines the catalytic 
site. It is situated at the C-terminal end of the β-barrel, in a cavity defined by the interface 
of the other monomer of the tight-dimer. This residue is in close proximity to Y133.  
R138 lies at the entrance to the active site cavity and its role in binding the carboxyl 
group of (S)-ASA has also been shown by site-directed mutagenesis.34 
 
The allosteric binding site 
Lysine binds at the exterior cleft of the tetramer formed at the tight-dimer interface. 
Several residues have to subtly rearrange in order to accommodate the binding; most 
notably H53, H56, E84, Y106, and Y107 from the opposite subunit.28,35  
 
The dimer-dimer interface 
Monomers A/C and B/D associate tightly to form dimers, which more loosely associate 
to form the tetrameric structure of wild-type DHDPS (Figure 1.2). The tight dimer 
interface includes the highly conserved residues Y106 and Y107. Their side chains 
interdigitate in the crystal structure of all DHDPS solved thus far, resulting in a 
hydrophobic, sandwich-like stacking of their aromatic rings.30 
 
The loose interface between monomers A/B and C/D is thought to involve a limited 
number of residues, resulting in a weak association.30,36 L197 is one of these residues and 
its mutation to an aspartate prevents the tight dimers from associating into a tetramer, due 
to the introduction of negative charge where there are normally hydrophobic interactions. 
The introduction of steric bulk at this position, by exchanging the leucine residue to a 
tyrosine, also results in a dimeric form of DHDPS.36 These mutant enzymes displayed 
less than 3% of the activity of the wild-type enzyme, indicating that the tetrameric 
structure of E. coli DHDPS is important for catalysis. 
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1.3.3 Reaction mechanism catalysed by DHDPS 
The current proposed catalytic mechanism of the DHDPS-catalysed reaction can be 
divided into three main steps. The first step involves Schiff base formation with pyruvate. 
(S)-ASA then binds to the active site, where it undergoes an aldol condensation reaction, 
followed by the release of the product (4S)-4-hydroxy-2,3,4,5-tetrahydro-(2S)-dipicolinic 
acid (HTPA).29 
 
 
Figure 1.3 Mechanism of the DHDPS-catalysed reaction.37  
 
 
Schiff base formation 
Schiff base formation is initiated by nucleophilic attack of the ε-amino group of the 
highly conserved K161 residue in the active site upon the keto group of pyruvate, 
resulting in the release of water (Figure 1.3, steps 1 and 2). Y133 is proposed to play a 
major role in this part of the reaction via stabilisation of the oxyanion intermediate and as 
a proton donor.29 
 1 
 
 2 
 
 3 
 
 4 
 
 5 
 
6 
 
    7 
 
8 
 
   9 
 
 10 
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Aldol condensation reaction 
The binding of pyruvate to the Schiff base is followed by tautomerisation to an enamine 
(Figure 1.3, step 3), which undergoes condensation with (S)-ASA (Figure 1.3, steps 4 and 
5). (S)-ASA can exist in two different forms in solution (Figure 1.4). There is some 
debate as to whether (S)-ASA binds as the free aldehyde or as the hydrated form; the 
latter appears to be gaining general acceptance.29,30,38-40 It has been observed that the 
hydrate of (S)-ASA is the predominant species in aqueous solution39,41 and that the active 
site can accommodate and coordinate this species.13,29  Assuming that the hydrate form of 
(S)-ASA is the species involved in this reaction, Y133 is in position to protonate one of 
the hydroxyl groups (Figure 1.3, step 4), while G186 coordinates the other one. The 
catalytic triad stabilises the tyrosine anion via a proton-relay to bulk solvent.27,29 
 
 
 
Figure 1.4 Two possible structures of (S)-ASA structure in solution. 
 
 
Cyclisation and product release 
Nucleophilic attack by the amine of the (S)-ASA moiety on the Schiff base results in 
cyclisation (Figure 1.3, step 7), followed by the release of the product (Figure 1.3, step 9). 
For the final steps of the reaction, deprotonation of the attacking amino group and 
transfer of a proton to the ε-amino group of K161 are necessary (Figure 1.3, step 6). 
Y133 is proposed to play a central role in these steps, as it is in position to coordinate the 
attacking amino group both before and after nucleophilic attack. Proton transfer to the ε-
amino group of K161 is also proposed to be mediated through the proton-relay triad.27,29 
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It was previously assumed that the product released was the dehydrated adduct 2,3-
dihydrodipicolinate (Figure 1.5).4 However, NMR studies have shown that the cyclic 
hydroxy imine product HTPA is released, and that the release of water had not 
occurred.29 This suggests that HTPA undergoes a non-enzymatic dehydration reaction 
under physiological conditions to generate 2,3-dihydrodipicolinate. However, this 
remains under debate, since the basic conditions used in the NMR experiment may have 
influenced the dehydration chemistry and accounted for the accumulation of the hydroxyl 
intermediate.6 
 
 
  
Figure 1.5 Two possible products of the DHDPS-catalysed reaction. 
 
 
1.3.4 Kinetic studies 
A ping-pong mechanism has been proposed for DHDPS based on kinetic studies.4,27,42-45 
This mechanism, also known as the substituted enzyme mechanism or the double 
displacement mechanism, requires that the two substrates, (S)-ASA and pyruvate, bind to 
the enzyme in a defined order, through a covalent enzyme-substrate intermediate, and 
that two independent products are released.46 This is consistent with the mechanism 
proposed in Figure 1.3, with H2O as the first released product (step 2). 
 
The reported Michaelis-Menten constants (Km) of DHDPS from E. coli for pyruvate 
range between 0.11-0.25 mM, whereas for (S)-ASA the values range between 0.11-0.12 
mM.4,29,37,45 Higher Km values for (S)-ASA have been observed for DHDPS from 
bacterial sources compared to that from plant sources. The values of Km for pyruvate vary 
considerably within plant and bacterial species.29  
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The observation of substrate inhibition by (S)-ASA at high concentrations is another area 
that has caused debate. Stahly (1969)47 first reported inhibition by (S)-ASA and suggested 
that it affected pyruvate binding, but not the maximal velocity, as predicted by a ping-
pong mechanism. Further studies have agreed with Stahly’s work.44,48-50 However, (S)-
ASA inhibition of DHDPS has not been observed in this laboratory.40,45 The difference in 
results with respect to inhibition by (S)-ASA demanded a re-evaluation of the data. 
Dobson et al. (2004)40 compared alternative preparations of (S)-ASA and suggested that 
apparent substrate inhibition is caused by an as yet unidentified inhibitor present in 
impure preparations and not by (S)-ASA. It was concluded that previous experiments 
documenting substrate inhibition could have resulted from artifacts associated with the 
ozonolysis preparation of (S)-ASA.  
 
 
1.3.5  Regulation of DHDPS by (S)-lysine 
Inhibition of the DHDPS-catalysed reaction by (S)-lysine was first observed in E. coli in 
1962.51 This work suggested that (S)-lysine is a competitive inhibitor with respect to (S)-
ASA. Evidence from kinetic and structural studies have since supported the idea that 
lysine is an allosteric inhibitor;4,29,35,42 however, the exact mechanism by which lysine 
exerts its regulatory effect is still open to debate.  
 
There have been three mechanisms proposed to explain how DHDPS is regulated by 
lysine. The first proposal involves the re-orientation of Y107, which is part of the 
catalytic triad, when lysine is bound.29,35 The second hypothesis is that upon re-
orientation of Y107, the flexibility of R138, which binds to the carboxyl group of (S)-
ASA, is compromised and this could inhibit DHDPS activity. It has been argued that in 
the final stages of the catalysis, cyclisation requires some flexibility in R138 so that the 
Schiff base can be formed.29,34 The third mechanism of inhibition proposed involves (S)-
lysine blocking the proton shuttle through a water channel, which connects the active site 
to the bulk solvent via a series of hydrogen bonds when lysine is bound.27   
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The level of inhibition of DHDPS by (S)-lysine varies widely and can be grouped into 
three classes:29 
(i) Plant enzymes, which are strongly inhibited by lysine with an I0.5 between 
0.01 and 0.05 mM.23,52-54  
(ii) Enzymes from E. coli,4 Bacillus sphaericus,55 and Methanobacterium 
thermoautotropicum,56 which are only weakly inhibited with an I0.5  between 
0.25 and 1.0 mM.  
(iii) DHDPS from most Gram-positive bacteria and Thermotoga57 (Gram-
negative), which appear not to be inhibited at all, with an I0.5 of more than 10 
mM.58-61  
 
1.3.6 Related enzyme N-acetylneuraminate lyase (NAL) 
Like DHDPS, N-Acetylneuraminate lyase (NAL) is a member of the (β/α)8 barrel 
proteins and the class I aldolase family. NAL is involved in the regulation of intracellular 
sialic acid concentration,31 catalysing the aldol cleavage of N-acetylneuraminate to form 
N-acetylmannosamine and pyruvate via a Schiff base intermediate. E. coli DHDPS 
displays significant sequence homology with respect to E. coli NAL, revealing important 
residues for their tertiary structure, active site and lysine binding site.  This sequence 
similarity is not restricted to the enzyme from E. coli, and several proteins from the NAL 
sub-family, from a variety of species have been shown to exhibit significant interspecies 
sequence and structural homology.33  
 
E. coli DHDPS residues T44, T45, Y133, K161, G186, Y107 and Y203 are conserved in 
E. coli
 
NAL. Alignment of the structures of DHDPS and NAL indicates these residues 
have the same spatial positioning. This led to the conclusion that the mechanism of Schiff 
base formation and the subsequent aldol reaction is likely to be conserved in both 
enzymes.29 Current opinion favours the entire (β/α)8 barrel protein family as having 
arisen from one ancestral protein, or from a limited number of ancestors, due to the 
deduced sequence similarity within the family.33  
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When lysine 161 was substituted to an alanine in Clostridium perfringens NAL by site-
directed mutagenesis, activity was completely removed.62  However, when the residue 
was mutated to an arginine, 3% of the original activity was still maintained. It was 
proposed that residual activity could be detected because the guanidinium group of 
arginine should still allow the formation of the Schiff base, but at a much slower rate than 
with the amino group of lysine 161. This is because this group is stabilised mesomerically 
and thus, the NH2 group of arginine is less nucleophilic than that of lysine. Although 
arginine has been shown to allow Schiff base formation in the work by Morris et al. 
(1996)63 using sodium borohydride to trap the intermediate, no further experimental work 
was conducted by Kruger et al. (2001)62  to confirm the ability of the NAL-K161R to 
form the covalent intermediate.  
 
 
1.4  Summary and aims of this project 
 
Although the mechanism of DHDPS has been studied in considerable detail, the absolute 
necessity for the active site lysine residue, K161, has, strikingly, never been established 
like in the NAL enzyme. The primary aim of this thesis is to address this gap in our 
understanding of DHDPS. The results of this study may shed some light on the 
evolutionary relationship between the two enzymes.  
 
The elucidation of the role of this residue has been achieved by generating and purifying 
two site-directed mutants of lysine 161, followed by their characterisation using steady-
state kinetics, far-UV CD, DSF and ITC, which are all described in Chapter three. 
Chapter two deals with the over-expression, purification and kinetic description of wild-
type DHDPS to provide baseline data for comparison with those obtained for the mutant 
enzymes, as well as including the over-expression and purification of DHDPR, which is 
the coupling enzyme used in the DHDPS kinetic assays. Chapter four includes the crystal 
structure of the mutants generated in order to detect any changes in the tertiary structure 
induced by the mutations. Chapter five is a discussion chapter, which brings together all 
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the information gathered in Chapters three and four. Chapter six contains all the 
experimental work pertaining to Chapters two to four. 
 
 
1.5   References  
 
1. Work, E., A new naturally occurring amino acid. Nature 1950, 165, 74-75. 
2. Work, E., The isolation of diaminopimelic acid from Corynebacterium diphteriae 
and Mycobcterium tuberculosis. Journal of Biochemistry 1951, 49, 17-23. 
3. Gilvarg, C., Biosythesis of diaminopimelic acid. Fin Lakaresallsk Handl 1960, 
19, 948-952. 
4. Yugari, Y.; Gilvarg, C., The condensation step in diaminopimelate synthesis. 
Journal of Biological Chemistry 1965, 240, 4710-4716. 
5. Shedlarski, J. G.; Gilvarg, C., The pyruvate-aspartic semialdehyde condensing 
enzyme of Escherichia coli. Journal of Biological Chemistry 1970, 245, 1362-
1373. 
6. Cox, R. J.; Sutherland, A.; Vederas, J. C., Bacterial diaminopimelate metabolism 
as a target for antibiotic design. Bioorganic Medical Chemistry 2000, 8, 843-871. 
7. Viola, R. E., The central enzymes of the aspartate family of amino acid 
biosynthesis. Accounts of Chemical Research 2001, 34, 339-349. 
8. Keeler, S. J.; Maloney, C. L.; Webber, P. Y.; Patterson, C.; Hirata, L. T.; Falco, S. 
C.; Rice, J. A., Expression of the de novo  high-lysine alpha-helical-coiled-coil 
proteins may significantly increase the accumulated levels of lysine in mature 
seeds of transgenic tobacco plants. Plant Molecular Biology 1997, 34, 15-29. 
9. Bright, S. W. J.; Shewry, R., Improvement of protein quality in cereals. Critical 
Review of Plant Sciences 1983, 1, 49-93. 
10. Monaghan, R. L.; Barrett, J. F., Antibacterial drug discovery- then, now and the 
genomics future. Biochemical Pharmacology 2006, 71, (7), 901-909. 
11. Pucci, M. J., Use of genomics to select antibacterial targets. Biochemical 
Pharmacology 2006, 71, (7), 1066-1072. 
Chapter One: Introduction  13 
   
12. Mills, S. D., When will the genomics investment pay off for antibacterial 
discovery? Biochemical Pharmacology 2006, 71, (7), 1096-1102. 
13. Hutton, C. A.; Perugini, M. A.; Gerrard, J. A., Inhibition of lysine biosynthesis: 
an evolving antibiotic strategy. Molecular BioSystems 2007, 3, 458-465. 
14. Scapin, G.; Blanchard, J. S., Enzymology of bacterial lysine biosynthesis. 
Advances in Enzymology and Related Areas of Molecular Biology 1998, 72, 279-
297. 
15. Richaud, F.; Richaud, C.; Ratet, P.; Patte, J., Chromosomal location and 
nucleotide sequence of the Escherichia coli dapA gene. Journal of Bacteriology 
1986, 166, 297-300. 
16. Richaud, F.; Richaud, C.; Haziza, C.; Patte, J., Isolement et purification de genes 
d'Escherichia coli K12 impliques dans la biosynthese de la lysine. Comptes 
Rendus de l'Acaddmie des Sciences. La vie des Sciences 1981, 293, 507-512. 
17. Bouvier, J.; Richaud, C.; Richaud, F.; Patte, J.; Stragier, P., Nucleotide sequence 
and expression of Escherichia coli dapB gene. Journal of Biological Chemistry 
1984, 258, 14829-14834. 
18. Cremer, J.; Eggeling, L.; Sahm, H., Cloning the dapA dapB cluster of the lysine-
secreting bacterium Corynebacterium glutamicum. Molecular & General 
Genetics 1990, 220, (3), 478-480. 
19. Chen, N. Y.; Jian, S. Q.; Klein, D. A.; Paulus, H., Organization and nucleotide-
sequence of the Bacillus subtilis diaminopimelate operon, a cluster of genes 
encoding the 1st 3 enzymes of diaminopimelate synthesis and dipicolinate 
synthase. Journal of Biological Chemistry 1993, 268, (13), 9448-9465. 
20. Pisabarro, A.; Malumbres, M.; Mateos, L. M.; Oguiza, J. A.; Martin, J. F., A 
cluster of three genes (dapA, orf2, and dapB) of Brevibacterium lactofermentum 
encodes dihydrodipicolinate synthase, dihydrodipicolinate reductase, and a third 
polypeptide of unknown function. Journal of Bacteriology 1993, 175, (9), 2743-
2749. 
21. Garcia-Rodriguez, F. M.; Zekri, S.; Toro, N., Characterization of the 
Sinorhizobium meliloti genes encoding a functional dihydrodipicolinate synthase 
Chapter One: Introduction  14 
   
(dapA) and dihydrodipicolinate reductase (dapB). Archives of Microbiology 2000, 
173, (5-6), 438-444. 
22. Kaneko, T.; Hashimoto, T.; Kumpaisal, R.; Yamada, Y., Molecular cloning of 
wheat dihydrodipicolinate synthase. Journal of Biological Chemistry 1990, 265, 
(29), 17451-17455. 
23. Frisch, D. A.; Gengenbach, B. G.; Tommey, A. M.; Sellner, J. M.; Somers, D. A.; 
Myers, D. E., Isolation and characterization of dihydrodipicolinate synthase from 
maize. Plant Physiology 1991, 96, (2), 444-452. 
24. Silk, G. W.; Matthews, B. F.; Somers, D. A.; Gengenbach, B. G., Cloning and 
expression of the soybean dapA gene encoding dihydrodipicolinate synthase. 
Plant Molecular Biology 1994, 26, (3), 989-993. 
25. Vauterin, M.; Jacobs, M., Isolation of a popular and an Arabidopsis thaliana 
dihydrodipicolinate synthase cDNA clone. Plant Molecular Biology 1994, 25, (3), 
545-550. 
26. Ghislain, M.; Frankard, V.; Jacobs, M., A dinucleotide mutation in 
dihydrodipicolinate synthase of Nicotiana sylvestris leads to lysine 
overproduction. Plant Journal 1995, 8, (5), 733-743. 
27. Dobson, R. C. Investigating the catalytic and regulatory mechanism of 
dihydropicolinate synthase. D. Phil. Thesis. University of Canterbury, 2003. 
28. Dobson, R. C.; Griffin, M. D.; Jameson, G. B.; Gerrard, J. A., The crystal 
structures of native and (S)-lysine-bound dihydrodipicolinate synthase from 
Escherichia coli with improved resolution show new features of biological 
significance. Acta Crystallographica Section D-Biological Crystallography 2005, 
61, (Pt 8), 1116-1124. 
29. Blickling, S.; Renner, C.; Laber, B.; Pohlenz, H. D.; Holak, T. A.; Huber, R., 
Reaction mechanism of Escherichia coli dihydrodipicolinate synthase 
investigated by X-ray crystallography and NMR spectroscopy. Biochemistry 
1997, 36, (1), 24-33. 
30. Mirwaldt, C.; Korndorfer, I.; Huber, R., The crystal structure of 
dihydrodipicolinate synthase from Escherichia coli at 2.5 Å resolution. Journal of 
Molecular Biology 1995, 246, (1), 227-239. 
Chapter One: Introduction  15 
   
31. Izard, T.; Lawrence, M. C.; Malby, R. L.; Lilley, G. G.; Colman, P. M., The three-
dimensional structure of N-acetylneuraminate lyase from Escherichia coli. 
Structure 1994, 2, 361-369. 
32. Delano, W. L. The PyMOL Molecular Graphics System. 2002. 
33. Lawrence, M. C.; Barbosa, J.; Smith, B. J.; Hall, N. E.; Pilling, P. A.; Ooi, H. C.; 
Marcuccio, S. M., Structure and mechanism of a sub-family of enzymes related to 
N-acetylneuraminate lyase. Journal of Molecular Biology 1997, 266, (2), 381-
399. 
34. Dobson, R. C.; Devenish, S. R.; Turner, L. A.; Clifford, V. R.; Pearce, F. G.; 
Jameson, G. B.; Gerrard, J. A., Role of arginine 138 in the catalysis and regulation 
of Escherichia coli dihydrodipicolinate synthase. Biochemistry 2005, 44, (39), 
13007-13013. 
35. Blickling, S.; Knablein, J., Feedback inhibition of dihydrodipicolinate synthase 
enzymes by L-lysine. Biological Chemistry 1997, 378, (3-4), 207-210. 
36. Griffin, M. D. Why is dihydrodipicolinate synthase a tetramer? D. Phil. Thesis. 
University of Canterbury, 2005. 
37. Dobson, R. C.; Valegard, K.; Gerrard, J. A., The crystal structure of three site-
directed mutants of Escherichia coli dihydrodipicolinate synthase: further 
evidence for a catalytic triad. Journal of Molecular Biology 2004, 338, (2), 329-
339. 
38. Shames, S.; Wedler, F., Homoserine kinase of Escherichia coli: kinetic 
mechanism and inhibition by L-aspartate semialdehyde. Archives of Biochemistry 
and Biophysics 1984, 235, 359-370. 
39. Coulter, C. V.; Gerrard, J. A.; Kraunsoe, J. A. E.; Moore, D. J.; Pratt, A. J., (S)-
Aspartate semi-aldehyde: synthetic and structural studies. Tetrahedron 1996, 52, 
(20), 7127-7136. 
40. Dobson, R. C.; Gerrard, J. A.; Pearce, F. G., Dihydrodipicolinate synthase is not 
inhibited by its substrate, (S)-aspartate beta-semialdehyde. Biochemistry Journal 
2004, 377, (Pt 3), 757-762. 
Chapter One: Introduction  16 
   
41. Tudor, D. W.; Lewis, T.; Robins, D. J., Synthesis of the trifluoroacetate salt of 
aspartic-acid β-semialdehyde, an intermediate in the biosynthesis of L-lysine, L-
threonine, and L-methionine. Synthesis 1993, 11, 1061-1062. 
42. Laber, B.; Gomis-Ruth, F. X.; Romao, M. J.; Huber, R., Escherichia coli 
dihydrodipicolinate synthase. Identification of the active site and crystallization. 
Biochemistry Journal 1992, 288, (Pt 2), 691-695. 
43. Borthwick, E. B.; Connell, S. J.; Tudor, D. W.; Robins, D. J.; Shneier, A.; Abell, 
C.; Coggins, J. R., Escherichia coli dihydrodipicolinate synthase: characterization 
of the imine intermediate and the product of bromopyruvate treatment by 
electrospray mass spectrometry. Biochemistry Journal 1995, 305, (Pt 2), 521-524. 
44. Karsten, W. E., Dihydrodipicolinate synthase from Escherichia coli: pH 
dependent changes in the kinetic mechanism and kinetic mechanism of allosteric 
inhibition by L-lysine. Biochemistry 1997, 36, (7), 1730-1739. 
45. Coulter, C. V.; Gerrard, J. A.; Kraunsoe, J. A. E.; Pratt, A. J., Escherichia coli 
dihydrodipicolinate synthase and dihydrodipicolinate reductase: kinetic and 
inhibition studies of two putative herbicide targets. Pesticide Science 1999, 55, 
887-895. 
46. Cornish-Bowden, A., Fundamentals of enzyme kinetics. Portland Press: London, 
1999. 
47. Stahly, D. P., Dihydrodipicolinic acid synthase of Bacillus licheniformis. 
Biochimie et Biophysica Acta 1969, 191, 439-451. 
48. Mazelis, M.; Whatley, F. R.; Whatley, J., The enzymology of lysine biosynthesis 
in higher plants. The occurrence, characterization and some regulatory properties 
of dihydrodipicolinate synthase. FEBS Letters 1977, 84, (2), 236-240. 
49. Wallsgrove, R. M.; Mazelis, M., The enzymology of lysine biosynthesis in higher 
plants: complete localization of the regulatory enzyme dihydrodipicolinate 
synthase in the chloroplasts of spinach leaves. FEBS Letters 1981, 116, (2), 189-
192. 
50. Kumpaisal, R.; Hashimoto, T.; Yamada, Y., Purification and characterization of 
dihydrodipicolinate synthase from wheat suspension cultures. Plant Physiology 
1987, 85, (1), 145-151. 
Chapter One: Introduction  17 
   
51. Yugari, Y.; Gilvarg, C., Coordinated end-product inhibition in lysine synthesis in 
Escherichia coli Biochimie et Biophysica Acta 1962, 62, 612-614. 
52. Kumpaisal, R.; Hashimoto, T.; Yamada, Y., Inactivation of wheat 
dihydrodipicolinate synthase by 3-bromopyruvate. Agricultural and Biological 
Chemistry 1989, 53, 355-359. 
53. Ghislain, M.; Frankard, V.; Jacobs, M., Dihydrodipicolinate synthase of Nicotiana 
sylvestris, a chloroplast-localized enzyme of the lysine pathway. Planta 1990, 
180, 480-486. 
54. Dereppe, C.; Bold, G.; Ghisalba, O.; Ebert, E.; Schar, H. P., Purification and 
characterization of dihydrodipicolinate synthase from pea. Plant Physiology 1992, 
98, (3), 813-821. 
55. Bartlet, A. T. M.; White, P. J., Regulation of the enzymes of lysine biosynthesis in 
Brevibacterium lactofermentum NCTC 9602 during vegetative growth. Journal of 
General Microbiology 1986, 132, 3169-3177. 
56. Bakhiet, N.; Forney, F. W.; Stahly, D. P.; Daniels, L., Lysine biosynthesis in 
Methanobacterium thermoautotropicum is by the diaminopimelic acid pathway. 
Current Microbiology 1984, 10, 195-198. 
57. Pearce, F. G.; Perugini, M. A.; McKerchar, H. J.; J.A., G., Dihydrodipicolinate 
synthase from Thermotoga maritima. Biochemical Journal 2006, 400, 359-366. 
58. Webster, F. H.; Lechowich, R. V., Partial purification and characterization of 
dihydrodipicolinic acid synthetase from sporulating Bacillus megaterium. Journal 
of Bacteriology 1970, 101, (1), 118-126. 
59. Yamakura, F.; Ikeda, Y.; Kimura, K.; Sasakawa, T., Partial purification and some 
properties of pyruvate-aspartic semialdehyde condensing enzyme from 
sporulating Bacillus subtilis. Journal of Biochemistry (Tokyo) 1974, 76, (3), 611-
621. 
60. Hoganson, D. A.; Stahly, D. P., Regulation of dihydrodipicolinate synthase during 
growth and sporulation of Bacillus cereus. Journal of Bacteriology 1975, 124, (3), 
1344-1350. 
61. Selli, A.; Crociani, F.; Di Gioia, D.; Fava, F.; Crisetig, G.; Matteuzzi, D., 
Regulation of dihydrodipicolinate synthase and diaminopimelate decarboxylase 
Chapter One: Introduction  18 
   
activity in Bacillus stearothermophilus. Italian Journal of Biochemistry 1994, 43, 
(1), 29-35. 
62. Kruger, D.; Schauer, R.; Traving, C., Characterization and mutagenesis of the 
recombinant N-acetylneuraminate lyase from Clostridium perfringens - insights 
into the reaction mechanism. European Journal of Biochemistry 2001, 268, (13), 
3831-3839. 
63. Morris, A.; Davenport, R. C.; Tolan, D. R., A lysine to arginine substitution at 
position 146 of rabbit aldolase changes the rate-determining step to Schiff base 
formation. Protein Engineering 1996, 9, (1), 61-67. 
 
 
Chapter Two 
 
Purification and kinetic analysis of  
wild-type DHDPS 
 
 
 
2.1 Introduction 
 
In order to examine the consequences of site-directed mutations on the kinetic properties 
of DHDPS, the kinetic properties of the wild-type enzyme first had to be determined. 
Thus, it was necessary to purify wild-type DHDPS. In addition, the assay used to collect 
the initial rate data uses dihydrodipicolinate reductase (DHDPR) as the coupling enzyme, 
so this enzyme also had to be purified. Strains of E. coli were available that had been 
transformed with the plasmids pBluescript and pETM11, containing the dapA1 and dapB 
genes (courtesy of Sean Devenish) respectively. These strains provide a simple and 
convenient means for over-expression of each of the enzymes. 
 
Following purification, two methods were used to assess the activity of DHDPS: the o-
aminobenzaldehyde assay and the coupled assay. The former method yields qualitative 
results, which were useful for following the purification of DHDPS, while the coupled 
assay was used to obtain accurate measurements of the initial rate of the enzyme-
catalysed reaction.2,3 
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2.2 Over-expression and purification of DHDPR 
 
DHDPR was over-expressed and purified using methods reported previously by Dobson 
et al. (2004).4 The dapB gene had already been cloned into the pETM11 plasmid and 
transformed into the BL21 (DE3) strain for induced expression of the N-terminal His-
tagged DHDPR protein (courtesy of Sean Devenish). The successful transformants were 
identified by conferred resistance to the antibiotic kanamycin. Protein expression was 
induced by the addition of isopropyl β-D-1-thiogalactopyranoside (IPTG), followed by 
overnight growth. The cells were harvested by centrifugation and washed with buffer. 
Disruption of the cell was achieved by sonication, which allowed the release of proteins, 
including DHDPR. Following centrifugation, the supernatant containing the crude 
enzyme was applied to a His-trap column. The success of the purification was assessed 
by SDS-PAGE and staining with Coomassie brilliant blue, which revealed a single band 
at the expected mass of 29 kDa (Figure 2.1). The increase in purity was reflected in an 
increase in specific activity (Table 2.1). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 SDS-PAGE following the purification of DHDPR. Lanes: 1, Sigmamarker, 
wide molecular weight range of the bands (from top) 97, 84, 66, 55, 45, 36, 29, 24, 20, 
10.2 and 6.5 kDa; 2, crude cell extract; 3, eluant from His-Trap column. 
 
 
 1     2       3 
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Table 2.1 Purification of DHDPR (from 3 L of culture). 
 Proteina 
(mg) 
Total 
activityb 
(unitsc) 
Specific 
activity 
(units mg-1) 
Yield total 
(%) 
Degree of 
purification 
(fold) 
Crude 2688 5908 2.20 100  
His-Trap 514 3790 7.37 64 3.4 
a
  Protein concentrations determined using the Bradford assay. 
b
  Activity determined using the quantitative coupled assay for DHDPR activity. 
c
  1 unit is defined as the consumption of 1 µmol NADPH s-1. 
 
 
2.3 Over-expression and purification of DHDPS 
 
The purification of DHDPS was based on the methods originally reported by Yugari and 
Gilvarg (1995),2 as modified by Dobson et al. (2004).4 E. coli DHDPS was over-
expressed from the AT997recA- strain that had been transformed with the pBluescript 
plasmid pJG001.5 Chapter three (section 3.3.1) details the reasons for the choice of this E. 
coli strain. The successful transformants were identified by conferred resistance to 
ampicillin and tetracycline antibiotics. The cells were grown overnight and harvested by 
centrifugation. The proteins were released from the cells by sonication and activity was 
detected using the o-aminobenzaldehyde assay, as described in section 2.4.1. DHDPS 
shows a relative thermostability, which enabled the introduction of the heat shock 
procedure as a purification step. Following heat shock to remove much of the protein in 
solution, ion exchange (Q-Sepharose) and hydrophobic interaction (phenyl-Sepharose) 
were utilized to further purify the protein. The success of these purification steps were 
assessed by SDS-PAGE with Coomassie brilliant blue staining, which revealed a single 
band corresponding to the expected monomeric mass of approximately 31.2 kDa (Figure 
2.2). The purification procedure resulted in an increase specific activity of over 10-fold 
(Table 2.2). 
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Figure 2.2   SDS-PAGE following the purification of wild-type DHDPS.  Lanes: 1, Sigma 
marker, wide molecular weight range of the bands (from top) 97, 84, 66, 55, 45, 36, 29, 
24, 20, 10.2 and 6.5 kDa; 2, crude cell extract; 3, heat shock; 4, eluant from Q-
Sepharose; 5, eluant from phenyl-Sepharose. 
 
 
Table 2.2 Purification of wild-type DHDPS (from 5 L of culture). 
 Proteina 
(mg) 
Total 
activityb 
(unitsc) 
Specific 
activity 
(units mg-1) 
Yield 
total 
(%) 
Degree of 
purification 
(fold) 
DHDPS      
Crude 2048 334 0.16 100  
Heat shock 1376 247 0.18 74 1.1 
Q-Sepharose 569 216 0.38 65 2.1 
phenyl-Sepharose 106 187 1.76 56 4.6 
a
  Protein concentrations determined using the Bradford assay. 
b
  Activity determined using the quantitative coupled assay for DHDPS activity. 
c
  1 unit is defined as the consumption of 1 µmol NADPH s-1. 
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2.4   Methods used to measure DHDPS activity 
 
2.4.1  o-Aminobenzaldehyde assay 
The reaction between DHDPS and its substrates in the presence of o-aminobenzaldehyde 
results in the formation of an unknown purple product (Figure 2.3) during an incubation 
period of about 30 minutes, the formation of which can be monitored at 540 nm.2,3 The 
intensity of the purple colouration can be increased by the addition of an acid after the 
incubation period. This qualitative assay is useful to detect DHDPS activity during the 
purification steps due to its high specificity and sensitivity to the enzyme. However, since 
it is only semi-quantitative,2 this method was not used for quantitative kinetic 
measurements. 
 
O2C
O
O
H
H3N CO2
NH2
CHO
Unknown
purple 
product
Pyruvate (S)-ASA o-Aminobenzaldehyde
 
 
Figure 2.3 o-Aminobenzaldehyde assay.2,3  
 
 
2.4.2 Coupled assay 
The reaction of DHDPS cannot be followed directly using the spectrophotometer but it 
can be followed indirectly by coupling it to the next reaction in the lysine biosynthetic 
pathway, which is catalysed by DHDPR. This reaction utilises NADPH, so a 
spectrophotometric assay can be used that exploits the large absorbance of reduced 
NADPH at 340 nm (Figure 2.4).6 Provided that the activity of DHDPR is high enough, 
the rate of NADPH oxidation recorded will correspond exactly to the rate of the DHDPS-
catalysed reaction. This quantitative assay described originally in Borthwick et al. 
(1995)7 and Coulter et al. (1999),8 but later modified by Dobson (2004),4 was used to 
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determine the kinetic parameters of wild-type DHDPS, which will be discussed in the 
next section. 
O
O2C
H
O
H3N CO2 NH
O2C CO2
OH
HTPAPyruvate (S)-ASA
N
H
CO2O2C
Tetrahydrodipicolinate
NADPH
NADP
measured at 340 nm
 
 
Figure 2.4 The coupled assay used to quantitatively measure DHDPS activity. The 
oxidation of NADPH by the coupling enzyme, DHDPR, is monitored at 340 nm.7,8  
 
 
2.5 Enzyme kinetics of E. coli DHDPS 
 
Initial rate data were collected using the coupled assay, with DHDPR present in 10-fold 
excess. The substrate concentrations used ranged between 0.2 x Km and 10 x Km 
according to the method of Cornish-Bowden.6 Thus, the concentration of (S)-ASA and 
pyruvate used varied between 0.04 mM and 1.25 mM. The rates were collected in 
duplicate and the experiment carried out on two independent occasions. No rate of 
reaction was observed between the two substrates in the absence of enzyme at the range 
of concentrations mentioned above; indicating that any rates observed in these assays 
DHDPS 
DHDPR 
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would be attributed to the enzyme-catalysed reaction. The computer programme Enzfitter 
(Biosoft Cambridge, UK) was used to analyse the initial rate data.  
 
As mentioned in Chapter one (section 1.3.4), DHDPS displays a ping-pong kinetic 
mechanism, also known as the double displacement mechanism. In the case of DHDPS, 
pyruvate binds to the enzyme first via the formation of a covalent enzyme-substrate 
intermediate, followed by the release of water and the formation of a Schiff base. The 
second substrate, (S)-ASA, then binds to the Schiff base to release the final product, 
HTPA.5,9 Overall, two independent products are released (Figure 1.3). 
 
The kinetic data obtained for wild-type DHDPS were fitted to both the ping-pong model 
(Equation (2.1)) and the ternary-complex model (Equation (2.2)). A ternary-complex 
mechanism implies that there is no longer a strict order of reaction sequences like in the 
ping-pong mechanism. The data were fitted to both models because the mutants 
generated may have a change in mechanism, and a comparison point was needed.   
 
Equation (2.1)6  υ = VAB / (KmBA + KmAB + AB)  
Equation (2.2)6  υ = VAB / (KmBA + KmAB + AB + KsAKmB)  
 
V is the maximal velocity, KmA and KmB are the Michaelis-Menten constants for the two 
substrates, A and B are the substrate concentrations and υ is the initial velocity. KsA is the 
binding constant for substrate A to the free enzyme form. The better model was chosen, 
based on the statistical parameters obtained for each fit (Table 2.3). 
 
Table 2.3 Comparison of the statistical parameters obtained when kinetic data for 
wild-type DHDPS were fitted to the ping-pong and ternary-complex models. 
Statistical Parameter Ping-pong model Ternary-complex model 
R2 0.98 0.95 
S.E. of fit 0.039 0.056 
F-Value 860 253 
p-value 3.8 x 10-25 2.1 x 10-18 
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The kinetic data fitted better to the classical ping-pong model with an R2 value of 0.98 
and lower standard errors and p-values than those obtained for the ternary-complex 
model. The kinetic values (Table 2.4) are consistent with values published in the 
literature. The KmPyruvate of (0.14-0.16) mM is similar to those published, which range 
between 0.11 mM8 and 0.25 mM.2 The KmASA values obtained using the coupled assay 
vary between 0.11 and 0.14 mM,2,5,8-10 which is identical to the value obtained in this 
work. The catalytic turnover number (kcat) of 45±3 s-1 agrees with values obtained by 
other workers in this laboratory.5,11 
 
 
Table 2.4 Kinetic parameters of wild-type DHDPS determined using the ping-pong 
model. 
 
 
 
 
 
 
 
 
The Enzfitter programme was also used to generate the direct plot, Lineweaver-Burk plot 
(1/rate vs 1/[substrate]), Eadie-Hofstee plot (rate/[substrate] vs rate) and a percentage 
residual plot of the data. The ping-pong model clearly fitted the data well, as evidenced 
by a tight grouping of points about the Lineweaver-Burk plots (Figures 2.5B and 2.6B) 
and Eadie-Hofstee plots (Figures 2.5C and 2.6C), except at the lowest substrate 
concentrations, where experimental error is largest.6 The residual plots (Figures 2.5D and 
2.6D) showed random scattering, indicating that there were no systematic experimental 
errors. 
 
 
 
Parameter Wild-type DHDPS 
kcat (s-1) 45±3 
KmPyruvate (mM) 0.15±0.01 
KmASA (mM) 0.12±0.01 
kcat/KmPyruvate (M-1s-1) (3.0±0.4) x 105 
kcat/KmASA (M-1s-1) (3.8±0.6) x 106 
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Figure 2.5 Kinetic analysis of wild-type DHDPS with respect to (S)-ASA. (A) is a 
direct plot, (B) is the Lineweaver-Burk plot, (C) is the Eadie-Hofstee plot, and (D) is a 
percentage residual plot of the data. R2=0.98 and p (F) <0.01 
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Figure 2.6 Kinetic analysis of wild-type DHDPS with respect to pyruvate. (A) is a 
direct plot, (B) is the Lineweaver-Burk plot, (C) is the Eadie-Hofstee plot, and (D) is a 
percentage residual plot of the data. R2=0.98 and p (F) <0.01 
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2.6  Lysine inhibition studies of wild-type E. coli DHDPS 
 
Lysine, the end-product of the biosynthetic pathway, has been found to be an allosteric 
inhibitor of DHDPS, as described in Chapter one (section 1.3.5). However, the precise 
regulatory mechanism is not completely understood. DHDPS displays different types of 
inhibition with respect to each of its substrates. The inhibition of DHDPS with respect to 
pyruvate has been determined to be partial and uncompetitive,5 but lysine has been found 
to be a partial non-competitive inhibitor with respect to (S)-ASA.5,10,11 
 
Data were collected by keeping one of the substrates at a saturating concentration and 
varying the concentration of the other substrate and lysine, as described in Cornish-
Bowden (1999).6 The lysine concentrations used varied between 0 mM and 5 mM. The 
concentrations of pyruvate varied between 0.04 mM and 2.5 mM, and for (S)-ASA, 
between 0.04 mM and 1.25 mM.  
 
Once again, the rates were collected in duplicate and the experiment repeated. The 
computer programme Enzfitter was used to analyse the initial rate data and to generate 
the plots, using the equations for partial uncompetitive (Equation (2.3)) and partial non-
competitive inhibition (Equation (2.4)). 
 
Partial uncompetitive inhibition 
Equation (2.3), which describes partial uncompetitive inhibition, was used to fit the data 
collected when (S)-ASA was kept at a constant concentration. 
 
Equation (2.3)6  υ = 1/ [1/ (V Ki + V’I)] [I+ Ki (1+ Ks/S)]  
 
Where V is the maximal velocity in the absence of the inhibitor, V’ is the maximal 
velocity in the presence of the inhibitor at a saturating concentration, I is the inhibitor 
concentration, S is the substrate concentration, Ki is the inhibitor constant, Ks is the 
substrate binding constant and υ is the initial velocity. 
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This type of inhibition demonstrates that the higher the lysine concentration, the lower 
the V and Ks values will be, since the inhibitor is binding to the enzyme-substrate 
complex only.6 
 
The data obtained fitted Equation (2.3) well, with a Ki value of (0.11-0.13) mM (Table 
2.5 and Figure 2.7), which is in good agreement with values published in the 
literature.10,12 The enzyme was found to be 92% inhibited at saturating levels of (S)-
lysine, which is exactly what was observed by Dobson et al. (2004).12 
 
 
Table 2.5 Lysine inhibition studies of wild-type DHDPS with respect to pyruvate. 
(S)-ASA was kept at a constant concentration of 1.25 mM.  
 
 
 
 
 
 
1
 α is the ratio of the maximal velocity without the  
inhibitor (V) to the maximal velocity at saturating levels  
of the inhibitor (V’).12  
 
 
 
 
 
 
 
 
 
 
 
 
Parameter Wild-type 
Inhibition type Partial uncompetitive 
α (%)1 8±1 
Ki (mM) 0.12±0.01 
Chapter Two: Purification and kinetic analysis of wild-type DHDPS  
 
31 
Figure 2.7 Lysine inhibition studies of wild-type DHDPS with respect to pyruvate. (A) 
is a direct plot, (B) is the Lineweaver-Burk plot, (C) is the Eadie-Hofstee plot, and (D) is 
a percentage residual plot of the data. R2=0.98 and p (F) <0.01 
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Partial non-competitive inhibition 
Lysine has been found to be a partial non-competitive inhibitor of DHDPS with respect to 
(S)-ASA, so the following equation was used to fit the kinetic data: 
 
Equation (2.4)6   υ = 1/ {[(Ki+I) / [VKi + V’I)] (1+Ks /S)} 
 
Enzymes that display this type of inhibition have reduced V but unchanged Km with 
increasing concentration of the inhibitor.6  
 
The data fitted well to Equation (2.4), with an R2 value of 0.98 and p (F) <0.01. DHDPS 
retained 8% of its original activity in the presence of saturating levels of the inhibitor and 
the Ki value obtained was 0.18±0.02 mM (Table 2.6 and Figure 2.8), which is in good 
agreement with values obtained in the literature.10,13 
 
 
Table 2.6 Lysine inhibition studies of wild-type DHDPS with respect to (S)-ASA. 
Pyruvate was kept at a constant concentration of 2.5 mM.  
 
 
 
 
1
 α is the ratio of the maximal velocity without the 
 inhibitor (V) to the maximal velocity at saturating  
 levels of the inhibitor (V’).12  
 
 
 
 
 
 
 
Parameter Wild-type 
Inhibition type Partial non-competitive 
α (%) 8±1 
Ki (mM) 0.18±0.02 
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Figure 2.8 Lysine inhibition studies of wild-type DHDPS with respect to (S)-ASA. (A) 
is a direct plot, (B) is the Lineweaver-Burk plot, (C) is the Eadie-Hofstee plot, and (D) is 
a percentage residual plot of the data. R2=0.98 and p (F) <0.01. 
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2.7 Summary 
 
DHDPS and DHDPR were both purified and the former was also kinetically 
characterised in this chapter using the coupled assay. The data obtained fitted the ping-
pong mechanism better than the ternary-complex model, as evidenced by a higher R2 
value for the fit as well as a higher F-value and lower standard errors and p-value (Table 
2.3). The Km value for (S)-ASA was 0.12±0.01 mM, while for pyruvate, it was 0.15±0.01 
mM. The catalytic turnover number was 45±3 s-1. 
 
In addition, lysine inhibition studies were carried out on DHDPS. Partial uncompetitive 
inhibition was observed when varying the concentration of pyruvate, with a Ki value of 
0.12±0.01 mM. DHDPS displayed partial non-competitive inhibition with respect to (S)-
ASA, with a Ki  ranging between 0.16 and 0.20 mM. The enzyme still retains 8% activity 
with respect to each substrate at saturating levels of the inhibitor.  
 
The values obtained in this chapter are consistent with those published in the literature 
and they provide the baseline data required for the characterisation of the mutants 
generated in the following chapter. 
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Chapter Three 
 
Site-directed mutagenesis and  
characterisation of lysine 161 mutants 
 
 
3.1   Introduction 
 
DHDPS is a member of the class I aldolases and a common feature in the enzymes from 
this family is the presence of a lysine residue within the active site that forms a Schiff 
base intermediate with the substrate. From the X-ray crystal structure of DHDPS from E. 
coli, and alignment of all DHDPS sequences, it was deduced that it is lysine 161 that 
forms the intermediate with the first substrate, pyruvate.1,2 Alignment of the structures of 
DHDPS and the homologous enzyme, NAL, indicates that lysine 161 has the same spatial 
positioning. This led to the conclusion that the mechanism of Schiff base formation is 
likely to be conserved in both enzymes, as discussed in Chapter one (section 1.3.6).2 
 
Kruger et al. (2001)3 used site-directed mutagenesis to substitute lysine 161 from 
Clostridium perfringens NAL to an alanine and found that enzyme activity was 
completely removed. However, when the residue was mutated to an arginine, activity 
could still be detected. Although lysine 161 has been unequivocally implicated in Schiff 
base formation in the DHDPS catalytic mechanism, the effect of mutating this residue, in 
a manner similar to that investigated by Kruger et al. (2001)3 for NAL, had not yet been 
investigated. In this chapter, the generation of the alanine and arginine site-directed 
mutants is described, to assess whether lysine 161 is absolutely essential for catalysis of 
DHDPS and, consequently, to assess the importance of the Schiff base in the reaction 
mechanism. Site-directed mutagenesis is a powerful technique as it allows the 
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introduction of specific changes in the amino acid sequence of an enzyme by utilising the 
polymerase chain reaction (PCR) and it is much less structurally disruptive than chemical 
modification.4  
 
The two mutants were purified to obtain material suitable for biochemical 
characterisation. Their kinetic parameters were determined using the coupled assay, and 
the results compared to those obtained for wild-type DHDPS, in Chapter two. In addition, 
far-ultraviolet circular dichroism spectroscopy, differential scanning fluorimetry and 
isothermal titration calorimetry were used to characterise the wild-type and mutant 
enzymes in this chapter. 
 
 
3.2  Site-directed mutagenesis 
 
The QuikChange site-directed mutagenesis kit (Stratagene) was used to introduce the 
specific changes in the dapA gene.  
 
3.2.1 Mutagenic primer design 
The primers were designed from the gene sequence of E. coli DHDPS determined by 
Gerrard.5 The primers used are shown in Table 3.1.  
 
 Table 3.1 Forward primers used for site-directed mutagenesis showing the codon 
changed underlined. 
 
 
Primer name Forward primer 
DHDPS-
K161A#1 
5’GGC GAA AGT AAA AAT ATT ATC GGA ATC GCA GAG GCA    
ACA GGG G3’ 
DHDPS-
K161R#1 
5’GGC GAA AGT AAA AAT ATT ATC GGA ATC AGA GAG GCA 
ACA GGG G3’ 
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Reactions were set up using a constant primer concentration with two template DNA 
concentrations to optimise amplification. Following temperature cycling, the product was 
digested with Dpn I endonuclease (incubation at 37oC for 2 hours). The nicked vector 
DNA incorporating the desired mutations was then transformed into Epicurian coli XL 1-
Blue chemically competent cells using the heat shock method.6  
 
3.2.2  Sequencing 
The mutant plasmids were sequenced to ensure the desired mutation had been introduced 
and that the integrity of dapA was intact after site-directed mutagenesis. Sequencing was 
performed by the Auckland Genomics Unit, using plasmid DNA prepared by the standard 
alkaline lysis plasmid preparation method, described in Chapter six (section 6.2.9). The 
electropherograms show that each sequence contained the desired change (Figure 3.1). 
 
 
  DHDPS-K161A            DHDPS-K161R 
 
 
      
Figure 3.1  Electropherograms showing the desired changes in the plasmid 
underlined. 
 
 
 
3.3  Over-expression and purification of DHDPS mutants 
 
3.3.1 Choice of E. coli strain and over-expression of the dapA gene  
It is essential to exclude the possibility of contamination with wild-type enzyme when 
dealing with the low residual activity of enzymes lacking a key catalytic group such as 
Chapter Three: Site-directed mutagenesis and characterisation of lysine 161 mutants  
 
 
39 
lysine 161. Traces of wild-type enzyme may arise in the preparation, either as a 
contaminant or because of natural errors of miscorporation.7 To prevent the possibility of 
interference from wild-type enzyme derived from the host chromosome, which would 
affect the biochemical assays during kinetic characterisation, the over-expression of 
DHDPS mutants was performed in the E. coli strain AT997recA-.  
 
The strain AT997 contains a non-functional DHDPS gene (dapA-), which has been found 
to be complemented by pJG001. In addition, the strain was made recA- to avoid 
homologous recombination between a plasmid-borne dapA mutant gene and the E. coli 
genome.8 The strain was grown and maintained in LB in the presence of tetracycline in a 
medium supplemented with DAP, to allow easy selection and confirmation of the dapA- 
phenotype. The DHDPS activity from this strain was examined prior to transformation to 
ensure that the enzyme being produced from the chromosome was indeed non-functional.  
 
3.3.2   Transformation of E. coli AT997recA- with DHDPS mutant plasmids 
The ability of transformants to complement the dapA- phenotype was assessed by 
growing them in the absence of DAP. Each mutant plasmid rescued the AT997recA- 
strain, suggesting that they retained sufficient DHDPS activity for survival.  
 
3.3.3  Purification of DHDPS mutants 
The AT997recA- cells that were transformed with the mutant plasmids were grown 
overnight and harvested by centrifugation. Each protein was purified as described in 
section 2.3. The increase in purity was reflected in an increase in specific activity for each 
of the mutants (Table 3.2).  The success of these purification steps was assessed by SDS-
PAGE with Coomassie brilliant blue staining, which revealed a single band 
corresponding to the expected monomeric mass of approximately 31.2 kDa in each case 
(Figure 3.2). 
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Table 3.2 Purification of DHDPS mutants (from 5 L of culture). 
  Proteina 
(mg) 
Total 
activityb 
(unitsc) 
Specific 
activity 
(units mg-1) 
Yield 
total 
(%) 
Degree of 
purification 
(fold) 
DHDPS-K161A      
Crude 2078 4.23 0.00200 100  
Heat shock 1246 2.51 0.00202 59 1.0 
Q-Sepharose 758 1.95 0.00257 78 1.3 
phenyl-Sepharose 127 1.12 0.00886 58 3.4 
DHDPS-K161R      
Crude 2186 16.5 0.00754 100  
Heat shock 1345 10.3 0.00765 62 1.0 
Q-Sepharose 445 7.13 0.0160 43 2.1 
phenyl-Sepharose 103 3.12 0.0304 19 4.0 
a
  Protein concentrations determined using the Bradford assay. 
b
  Activity determined using the quantitative coupled assay for DHDPS activity. 
c
  1 unit is defined as the consumption of 1 µmol NADPH s-1. 
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            A  DHDPS-K161A                                                            B  DHDPS-K161R     
       
  
 
Figure 3.2   SDS-PAGE following the purification of the DHDPS mutants. 
A  DHDPS-K161A Lanes: 1, Sigmamarker, wide molecular weight range of 
the bands (from top) 97, 84, 66, 55, 45, 36, 29, 24, 20, 10.2 and 6.5 kDa; 2, crude 
cell extract; 3, heat shock; 4, eluant from Q-Sepharose; 5, eluant from phenyl-
Sepharose. 
B  DHDPS-K161R Lanes: 1, Sigmamarker; 2, crude cell extract; 3, heat 
shock; 4, eluant from Q-Sepharose; 5, eluant from phenyl-Sepharose. 
 
 
 
3.4  Stability of DHDPS-K161A and DHDPS-K161R  
 
It is not uncommon for an enzyme to lose its activity under in vitro conditions. 
Neglecting enzyme inactivation can result in errors in both estimating the kinetic 
parameters and reporting the mechanisms of enzyme action.9 Therefore, it is important to 
know if enzyme inactivation is affecting an enzyme assay. The most commonly used 
method to determine the stability of an enzyme under assay conditions is to compare 
progress curves of the product formation at different enzyme concentrations. If the 
enzyme is stable, the plots of synthesised product against time, multiplied by the enzyme 
concentration should be superimposable. This test was developed by Michaelis and 
        1   2     3     4     5         1   2     3     4     5 
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Davidsohn,10 and later systematically adapted by Selwyn.11 Both DHDPS mutants were 
stable under the assay conditions and therefore suitable for kinetic analysis (Figure 3.3). 
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Figure 3.3  Selwyn’s test for enzyme stability: A, DHDPS-K161A: 50 µL (▲), 100 µL 
(♦) and 150 µL (■); B, DHDPS-K161R: 25 µL (♦), 50 µL (■) and 75 µL (x). 
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3.5  Enzyme kinetics of E. coli DHDPS K161 mutants 
 
The kinetic data were fitted to the ping-pong model (Equation (1)) and the ternary- 
complex model (Equation (2)) as described in section 2.5. Both models showed the same 
standard errors associated with the kinetic constants and the same R2 values, unlike the 
pattern observed in the wild-type enzyme (Tables 3.3 and 3.4). Thus, the F- and p-values 
were used to determine which model gave the better fit, which was the ternary-complex 
mechanism.  
 
Table 3.3 Comparison of the statistical parameters obtained when kinetic data for 
DHDPS-K161A were fitted to the ping-pong and ternary-complex models. 
Statistical Parameter Ping-pong model Ternary-complex model 
R2 0.99 0.99 
S.E. of fit 4.4 x 10-5 4.4 x 10-5 
F-Value 860 1300 
p-value 1.1 x 10-30 2.6 x 10-32 
 
 
Table 3.4 Comparison of the statistical parameters obtained when kinetic data for 
DHDPS-K161R were fitted to the ping-pong and ternary-complex models. 
Statistical Parameter Ping-pong model Ternary-complex model 
R2 0.98 0.98 
S.E. of fit 1.9 x 10-4 1.9 x 10-4 
F-Value 300 470 
p-value 2.3 x 10-30 9.3 x 10-32 
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Table 3.5  Kinetic parameters obtained for DHDPS-K161A and DHDPS-K161R 
using the ternary-complex model compared with wild-type DHDPS (fitted with the ping-
pong model). 
 
 
 
 
 
 
 
1
 As determined in Chapter two using the ping-pong model. 
 
 
3.5.1 DHDPS-K161A kinetics 
The initial rate data fitted the ternary-complex mechanism well, which can be seen in 
Figures 3.4 and 3.5, except at the lowest substrate concentrations, as observed for wild-
type DHDPS (section 2.5). The R2 values were 0.99 and the p (F) <0.01 in both instances. 
The kcat value was found to be 0.06±0.02 s-1 – about 0.1% of the activity observed for the 
wild-type (Table 3.5). The Km values were both found to be somewhat greater than that of 
the wild-type. The KmPyruvate was 0.45±0.04 mM and KmASA was 0.23±0.02 mM, 
compared to 0.15±0.01 mM and 0.12±0.01 mM for the wild-type respectively. 
 
3.5.2 DHDPS-K161R kinetics 
Again, the data collected fitted the ternary-complex model well (Figures 3.6 and 3.7), 
except at the lowest substrate concentrations, as observed for wild-type DHDPS and 
DHDPS-K161A. The kcat was found to be 0.16±0.06 s-1 – less than 0.4% of the wild-type 
(Table 3.5). The KmPyruvate was increased over 2-fold (0.57±0.06 mM), while the KmASA 
remained the same as that of wild-type DHDPS (0.12±0.01 mM). The R2 for both fits was 
0.98 and the p (F) value was much less than 0.01. 
 
Parameter Wild-type1 K161A K161R 
kcat (s-1) 45±3 0.06±0.02 0.16±0.06 
Relative  kcat (%) 100 0.13 0.35 
KmPyruvate (mM) 0.15±0.01 0.45±0.04 0.57±0.06 
KmASA (mM) 0.12±0.01 0.23±0.02 0.12±0.01 
kcat/KmPyruvate (M-1s-1) (3.0±0.4)x105 (7.5±3.0)x103 (3.6±1.7)x103 
kcat/KmASA (M-1s-1) (3.8±0.6)x106 (3.8±1.5)x103 (7.5±3.6)x103 
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Figure 3.4 Kinetic analysis of DHDPS-K161A with respect to pyruvate. (A) is a direct 
plot, (B) is the Lineweaver-Burk plot, (C) is the Eadie-Hofstee plot, and (D) is a 
percentage residual plot of the data. R2=0.99 and p (F) <0.01 
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Figure 3.5 Kinetic analysis of DHDPS-K161A with respect (S)-ASA. (A) is a direct 
plot, (B) is the Lineweaver-Burk plot, (C) is the Eadie-Hofstee plot, and (D) is a 
percentage residual plot of the data. R2=0.99 and p (F) <0.01 
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Figure 3.6 Kinetic analysis of DHDPS-K161R with respect to pyruvate. (A) is a direct 
plot, (B) is the Lineweaver-Burk plot, (C) is the Eadie-Hofstee plot, and (D) is a 
percentage residual plot of the data. R2=0.98 and p (F) <0.01 
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Figure 3.7 Kinetic analysis of DHDPS-K161R with respect to (S)-ASA. (A) is a direct 
plot, (B) is the Lineweaver-Burk plot, (C) is the Eadie-Hofstee plot, and (D) is a 
percentage residual plot of the data. R2=0.98 and p (F) <0.01 
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3.6 Lysine inhibition studies 
 
3.6.1 DHDPS-K161A lysine inhibition 
This mutant showed the same type of inhibition as the wild-type with respect to both 
substrates, indicating that this mutation does not interfere with the lysine binding site 
(Figures 3.8 and 3.9). DHDPS-K161A showed partial uncompetitive inhibition in relation 
to pyruvate, with a Ki value of 0.14±0.01 mM (Table 3.4), compared to 0.12 ±0.01 mM 
for the wild-type. The Ki value with respect to (S)-ASA was 0.23±0.04 mM, whereas the 
wild-type enzyme had a Ki value of 0.18±0.02 mM. The type of inhibition remained 
partial non-competitive. At saturating levels of lysine, this mutant was about 92% 
inhibited, exactly as observed in the wild-type (Table 3.4).  
 
3.6.2 DHDPS-K161R lysine inhibition  
Like DHDPS-K161A, this mutant behaved in a similar manner to the wild-type with 
regards to lysine inhibition (Figures 3.10 and 3.11). Partial uncompetitive inhibition was 
again observed with respect to pyruvate and partial non-competitive inhibition was 
observed with respect to (S)-ASA (Table 3.4). The Ki and the alpha values were also 
similar to wild-type DHDPS.  
 
Table 3.4 Lysine inhibition studies of DHDPS-K161A and DHDPS-K161R 
compared with wild-type DHDPS. The inhibition types are all partial. 
 
Wild-type1 K161A K161R 
Varied [Pyruvate] 
   
Inhibition type Uncompetitive Uncompetitive Uncompetitive 
α (%)2 8±1 8±1 10±2 
Ki (mM) 0.12±0.01 0.14 ±0.01 0.14±0.01 
Varied [ASA]  
  
Inhibition type Non-competitive Non-competitive Non-competitive 
α (%)2 8±1 7±1 7±1 
Ki (mM) 0.18±0.02 0.23 ±0.04 0.14±0.01 
1
 As determined in Chapter two. 
2
 α is the ratio of the maximal velocity without the inhibitor (V) to the maximal velocity at saturating 
levels of the inhibitor (V’).12  
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Figure 3.8 Lysine inhibition of DHDPS-K161A with respect to pyruvate. (A) is a 
direct plot, (B) is the Lineweaver-Burk plot, (C) is the Eadie-Hofstee plot, and (D) is a 
percentage residual plot of the data. R2=0.96 and p (F) <0.01 
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Figure 3.9 Lysine inhibition of DHDPS-K161A with respect to (S)-ASA. (A) is a 
direct plot, (B) is the Lineweaver-Burk plot, (C) is the Eadie-Hofstee plot, and (D) is a 
percentage residual plot of the data. R2=0.98 and p (F) <0.01 
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Figure  3.10 Lysine inhibition of DHDPS-K161R with respect to pyruvate. (A) is a 
direct plot, (B) is the Lineweaver-Burk plot, (C) is the Eadie-Hofstee plot, and (D) is a 
percentage residual plot of the data. R2=0.99 and p (F) <0.01 
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Figure 3.11 Lysine inhibition of DHDPS-K161R with respect to (S)-ASA. (A) is a 
direct plot, (B) is the Lineweaver-Burk plot, (C) is the Eadie-Hofstee plot, and (D) is a 
percentage residual plot of the data. R2=0.98 and p (F) <0.01 
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3.7   Sodium borohydride inactivation test 
 
The reducing agent sodium borohydride can be used to detect the formation of a Schiff 
base between an enzyme and pyruvate by inactivation of the enzyme, due to the reduction 
of the C=N bond (Figure 3.12).13 This reagent was used in this work to examine whether 
a Schiff base could still be formed between the first substrate pyruvate and the two K161 
mutants generated. As seen in Table 3.5, the two mutants of DHDPS were not inactivated 
when incubated with pyruvate and the reducing agent, unlike the wild-type enzyme, 
suggesting that a Schiff base is not formed. In the presence of the second substrate, (S)-
ASA, the activity remained the same for each enzyme, as expected. The difference in 
results obtained for the mutant enzymes and wild-type DHDPS also rules out the 
possibility of wild-type enzyme contamination. 
 
N
H
CO2
NaBH4 H
N
Enzyme Enzyme CO2
 
 
Figure 3.12 Reduction of Schiff base by NaBH4.13 
 
  
Table 3.5 Percentage of activity remaining of wild-type and K161 mutants after 
treatment with NaBH4, in the presence and absence of substrates. 
 Activity Remaining (%) 
 Wild-type  K161A K161R 
Enzyme 100 100 100 
Enzyme +  NaBH4 91 98 97 
Enzyme +  NaBH4 + pyruvate 0.2 84 78 
Enzyme +  NaBH4 + (S)-ASA 87 93 89 
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3.8   Far-ultraviolet circular dichroism spectroscopy 
Far-UV CD spectroscopy is a widely used technique for obtaining information about the 
secondary structure composition of a protein.14 In this work, CD spectra were obtained 
for both mutant enzymes and they were compared to that of wild-type DHDPS, in order 
to establish if their secondary structure in solution had been altered upon introduction of 
the mutations. It is clear from Figure 3.13, which shows all spectra overlaid, that the 
secondary structures of DHDPS-K161A and DHDPS-K161R are similar to that of wild-
type DHDPS. All three spectra are comprised of double minima at 208 nm and 222 nm, 
which is characteristic of a predominantly α-helical structure.7 Thus, the introduction of 
the mutations at position 161 did not disrupt protein folding in solution. 
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Figure 3.13 Overlaid CD spectra of wild-type DHDPS (♦), DHDPS-K161A (■) and 
DHDPS-K161R (▲). 
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3.9  Differential scanning fluorimetry (DSF) 
 
DSF can be used to detect low molecular weight ligands that can bind and stabilise a 
particular protein.15 The basis for this technique is that at the temperature at which a 
protein unfolds, its hydrophobic portions become exposed and can then interact with a 
fluorescent dye, which in this case was Sypro Orange. This results in a significant 
increase in the fluorescence emitted by the dye.16 The higher the temperature at which 
this occurs, the higher the stability of the enzyme. The fluorescence then starts to 
decrease, probably due to precipitation of the complex formed between the fluorescent 
probe and the denatured protein or due to aggregation. 
 
It has been suggested that DHDPS is stabilised by its first substrate, pyruvate, due to a 
tighter packing of the protein structure upon formation of the Schiff base.17 This 
anecdotal observation was confirmed during this work using DSF, where the mutant 
enzymes were screened against a saturating concentration of pyruvate and compared to 
the wild-type enzyme, at temperatures ranging from 20oC to 90oC. This experiment was 
carried out in triplicate and the standard error was 0.10oC.  
 
The Boltzmann model (Equation 3.1) was used to obtain the temperature midpoint for 
each protein unfolding transition, Tm, from the fluorescence data gathered. 
 
Equation (3.1) 
 
 
Where y is the fluorescence intensity at temperature T, LL and UL are the values of 
minimum and maximum intensities, respectively, and a denotes the slope of the curve 
within Tm.16 
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Figure 3.14 Average thermal shift assay result for the wild-type and mutant enzymes 
generated screened against a saturating concentration of pyruvate (100 mM). —Wild-
type DHDPS, — Wild-type DHDPS + pyruvate, —DHDPS-K161A, —DHDPS-K161A + 
pyruvate, —DHDPS-K161R and —DHDPS-K161R + pyruvate.
 
 
 
There is a clear shift of the melting curve to the right when pyruvate is added to wild-type 
DHDPS (Figure 3.14). However, the shift in the curve is much smaller when pyruvate is 
added to the mutant enzymes. The average Tm values obtained when each enzyme was 
mixed with pyruvate were compared to the average Tm values obtained for the enzyme on 
its own. Wild-type DHDPS showed an average increase in Tm of 9.9oC in the presence of 
pyruvate (Figure 3.15). The melting temperature for DHDPS-K161A and DHDPS-
K161R also increased upon addition of pyruvate (∆Tm values of 2.4oC and 1.9oC 
respectively), but to a lesser extent than for the wild-type enzyme. This suggests that the 
stabilisation of E. coli DHDPS is largely dependent on Schiff base formation, although 
some stabilisation is afforded by pyruvate binding, even when the covalent adduct does 
not form. 
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Figure 3.15 Midpoint temperatures of the protein-unfolding transition (Tm) for wild-
type DHDPS and DHDPS mutants in the absence (■) and in the presence (■) of pyruvate. 
Standard error < 0.10oC. 
 
 
 
 
3.10 Isothermal titration calorimetry (ITC) 
 
ITC is a technique used to measure the energy released or absorbed during a chemical 
reaction between two components.18 Interpretation of the energy change can allow the 
determination of the magnitude of the binding affinity (Kb) and also the magnitude of the 
enthalpy (∆H) and entropy (∆S) changes from a single experiment. ITC has thus found 
widespread applicability in the study of biological systems involving protein-ligand, 
protein-nucleic acid, and protein-protein interactions.19 
 
Workers in this laboratory have found that the binding of wild-type DHDPS towards 
pyruvate is a low-affinity interaction.20,21 Wiseman et al. noted that the shape of a binding 
isotherm for a simple non-interacting one-site model changes according to the product of 
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the association constant (Kb) and the receptor concentration ([M]t(0)), which they referred 
to as the c value.22 For receptors with several identical non-interacting binding sites, the c 
value is defined by Equation (3.2). 
 
Equation (3.2) c = n Kb [M]t(0) 
 
Where n is the number of binding sites. A major limitation of ITC in the study of low-
affinity systems such as for the interaction between DHDPS and pyruvate is the need for 
high protein concentrations in order to obtain c values between 10 and 500, which is the 
range of values where curve fitting is thought to produce reliable thermodynamic 
parameters.23  
 
In a recent study, it was concluded that the difficulty in obtaining accurate 
thermodynamic information for low-affinity systems under low c values could be 
overcome if four criteria are met.23  Firstly, a sufficient portion of the binding isotherm 
needs to be used for analysis. This was ensured by using seven equivalents of pyruvate 
per binding site. The binding stoichiometry must also be known, as well as the 
concentrations of the ligand and the protein. The second criterion, of knowing the binding 
stoichiometry, was met based on crystallographic studies, which show DHDPS as a 
tetramer with four identical binding sites for pyruvate. This gives n a value of four. The 
third criterion was also met, as the concentration of each enzyme was determined in 
triplicate using A280 and the concentration of pyruvate by dilution from a stock pyruvate 
solution of a known concentration. Lastly, adequate signal-to-noise was also maintained 
during the titration.   
 
In this work, ITC experiments were carried out to determine the binding of both DHDPS-
K161A and DHDPS-K161R to pyruvate. Titration of wild-type DHDPS at similar 
concentrations to both mutant enzymes was also carried out, against the same relative 
concentrations of pyruvate, to provide a comparison point. There was no discernible heat 
produced upon binding of pyruvate to the mutant enzymes compared to the wild-type 
enzyme (Figure 3.16). Therefore, a specific binding model for the mutant enzymes could 
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not be invoked. This indicates that there is no measurable binding event occurring 
between the mutant enzymes and the first substrate, confirming that lysine 161 plays a 
crucial role towards pyruvate-binding, presumably via the intermediacy of a 
thermodynamically favourable Schiff base. Furthermore, the lack of the heat evolved in 
response to ligand injection implies that no other external non-active site binding residues 
are participating in the formation of Schiff base like structures.  
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Figure 3.16 ITC profiles obtained for titrations of pyruvate into wild-type DHDPS at 
0.27 mg/mL (A), DHDPS-K61A at 0.28 mg/mL (B) and DHDPS-K161R at 0.34 mg/mL 
(C). The top graphs show the raw data for 55 injections of pyruvate into a 20 mM HEPES 
buffered DHDPS solution at 25oC. The bottom graphs show heat released as a function 
of pyruvate added. The software accounts for the small differences in protein 
concentrations when attempting to fit a curve though the data. Data fitting could not be 
performed for the mutant enzymes due to the lack of heat generated. 
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3.11 1H Nuclear magnetic resonance (NMR) spectroscopy 
 
In the current proposed mechanism for DHDPS (Figure 1.3), the tautomerisation of the 
Schiff base to an enamine species creates the nucleophile that attacks (S)-ASA. This is 
followed by cyclisation, which leads to the release of HTPA from the active site. In 
section 3.7, it was shown by a sodium borohydride inactivation test, that the mutant 
enzymes are unable to form the covalent intermediate. Nevertheless, catalytic rates could 
still be measured, which were significantly greater than those in the absence of enzyme 
(section 2.5). Thus, the question arose as to which species acts as the nucleophile in the 
mutant enzymes, since the reaction can still proceed in the absence of the Schiff base, 
although at a much slower rate than with the wild-type enzyme. 
 
In order to examine whether the enolisation of pyruvate to an enol species could explain 
the detection of rate enhancements, the ability of the mutant enzymes to catalyse 
hydrogen-deuterium exchange of pyruvate was tested using NMR. This was done in 
collaboration with Andrew Muscroft-Taylor. The loss of the methyl protons from 
pyruvate can be followed by the decrease of the hydrogen 1H NMR signal as deuterium 
atoms are incorporated into the methyl group (Figure 3.17).24 The development of the 
splitting of the methyl peak of pyruvate is a consequence of 1H-2D coupling, resulting in 
the incorporation of deuterium which has a spin isotope number of s = 1.  
 
The chemical shift data for pyruvate and its deuterated analogues, in parts per million, are 
as follows: H3-pyruvate 2.36 (singlet), H2D-pyruvate 2.35 (triplet, J = 2.23 Hz) and D2H-
pyruvate 2.33 (quintet, J = 2.25 Hz). The large peak at 4.80 ppm, due to water in the 
solvent, was suppressed using a PRESAT pulse sequence, allowing adequate resolution 
of the signals from 0 to 4 ppm. The methyl peaks of t-butanol were used as internal 
standards for NMR measurements, referenced as a singlet at 1.24 ppm.25 The exchange of 
pyruvate in D2O in both the absence of enzyme and in the presence of an enzyme which 
is not known to accelerate the rate of enolisation of pyruvate were followed as negative 
controls. The control enzyme used in this work was DHDPR, which does not use a Schiff 
base intermediate for catalysis.  
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Figure 3.17 1H-NMR spectra of H3-pyruvate in D2O in the presence of wild-type 
DHDPS, illustrating 1H to 2D exchange at the time intervals 0 hours, 4 hours, 8 hours, 26 
hours and 80 hours. 
  
 
Figure 3.18 Integral ratios from NMR spectra measured at 10 minute time intervals 
for pyruvate in D2O in the presence of wild-type DHDPS (♦), DHDPS-K161A (■), 
DHDPS-K161R (▲), DHDPR (▼) and no enzyme (●). 
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The rapid decline in the pyruvate proton integral ratio for wild-type DHDPS indicates 
that this enzyme is much faster at catalysing the hydrogen-deuterium exchange of 
pyruvate than D2O alone (Figure 3.18). On the other hand, the mutant enzymes did not 
seem to catalyse the exchange of hydrogen atoms between pyruvate and D2O, 
presumably because of their inability to form a Schiff base.  The exchange rates observed 
were similar to those obtained for the control experiments (in the absence of enzyme and 
in the presence of the control protein, DHDPR). These results suggest that the rate of 
enolisation of the keto form of pyruvate to its enol tautomer is unchanged in DHDPS-
K161A and DHDPS-K161R catalysed mechanism. 
 
 
3.12 Discussion 
 
As mentioned in section 3.1, lysine 161 was identified as being involved in the formation 
of a Schiff base intermediate with the ketone group of the first substrate, pyruvate.1,2 The 
present study provides further evidence for the importance of this conserved residue, as 
demonstrated by the dramatic loss of activity observed in both lysine 161 mutants. The 
mutation of lysine 161 to an alanine resulted in an enzyme that retained only 0.1% wild-
type activity. The change of lysine 161 to an arginine also resulted in a significant 
decrease in activity, with less than 0.4% activity remaining. However, the most surprising 
finding was that mutation of lysine 161 did not completely abolish enzyme activity. This 
contrasts with what is observed in the homologous enzyme NAL, where the K161A 
mutant was inactive.  
 
An interesting finding was a shift in the kinetic mechanism, from the ping-pong to the 
ternary-complex mechanism, after the introduction of the mutations. This shift indicates a 
relaxation in the order of reaction steps during catalysis for the K161 mutants. Closer 
inspection of the Km values shows that the first half reaction, which involves pyruvate 
binding and Schiff base formation, is slightly affected, as evidenced by a 3-fold increase 
in the Michaelis-Menten constant with respect to pyruvate for both mutants. An increase 
in the KmPyruvate values were expected as the Schiff base-forming residue was removed, 
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however the small magnitude of the increase was a surprise. The ITC experiments 
showed that even though both mutants still retained activity, there is no measurable 
energy change occurring in the reaction between the mutant enzymes and pyruvate. The 
kinetic and ITC data confirm that lysine 161 plays a crucial role towards pyruvate-
binding and that a mutation at this position affects the first half reaction, which agrees 
with sequence alignment experiments as well as the crystallography data obtained for 
wild-type DHDPS in the presence of pyruvate. There was little or no change in KmASA, 
indicating that the removal of lysine 161 did not affect the second half reaction, which is 
to be expected, since lysine 161 is not involved in (S)-ASA binding according to the 
current proposed mechanism shown in section 1.3. 
 
Treatment with NaBH4 provides evidence that a Schiff base is not formed when pyruvate 
associates with either of the mutant enzymes generated. This is confirmed by DSF, which 
shows that the mutant enzymes are stabilised to a lesser extent in the presence of 
pyruvate than the wild-type enzyme, presumably due to their inability to form a Schiff 
base. These tests, combined with the detection of residual activity, demonstrate that 
covalent catalysis represents only part of the total lowering of the free energy of 
activation of the DHDPS-catalysed reaction. Hydrogen-deuterium exchange of pyruvate 
via NMR suggests that the rate of enolisation of the keto form of pyruvate to its enol 
tautomer is unchanged in DHDPS-K161A and DHDPS-K161R catalysed mechanism. 
 
The behaviour of the K161 mutants with respect to lysine inhibition was also investigated 
in this chapter. The mutants behaved in an entirely analogous fashion to the wild-type 
DHDPS. Not only were the same types of inhibition displayed and similar Ki values were 
observed but at saturating inhibitor levels, the enzymes were 92% inhibited as is the wild-
type enzyme. This demonstrates the lack of involvement of lysine 161 in the regulation of 
DHDPS by (S)-lysine. 
 
CD spectroscopy showed that the mutations did not grossly perturb the secondary 
structure of the enzyme in solution. The crystal structure of these mutants will be detailed 
in the following chapter in the presence and in the absence of pyruvate to allow a further 
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understanding of how DHDPS can perform catalysis in the absence of its key active site 
residue, lysine 161, and to rule out the possibility that their tertiary and quaternary 
structures have been altered. 
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 Chapter Four 
 
Crystal structures of  
DHDPS-K161A and DHDPS-K161R 
 
 
4.1 Introduction 
 
The results from Chapter three showed a dramatic decrease in enzyme activity when 
lysine 161 is replaced by either an alanine or an arginine in DHDPS. CD spectroscopy 
confirmed that the secondary structures of the mutant enzymes were identical to that of 
the wild-type enzyme. In this chapter, X-ray crystallography was used to determine their 
structure in order to rule out the possibility that this decrease in activity was due to gross 
alterations in their tertiary or quaternary structures. The structural information obtained 
from X-ray crystallography has proved to be a key factor in the investigation of enzyme 
mechanisms. This technique allows the construction of an electron density map that 
shows the arrangement in space of the atoms in a protein, using the information obtained 
from the X-ray diffraction patterns of suitable crystals.1 Protein crystallography is not a 
trivial task, as protein crystals of sufficient size and quality are needed, so that 
interpretable diffraction patterns can be obtained.  
 
This chapter details the structures of both DHDPS-K161A and DHDPS-K161R, and 
compares them to the structure of the wild-type enzyme that had previously been solved 
by Dobson et al.2 to a resolution of 1.9 Å. However, in order to fully understand how an 
enzyme works, it is necessary to determine the structure of not only the enzyme but also 
the structures of the complexes of the enzyme with its substrates. In this chapter, the 
structure of DHDPS-K161A and DHDPS-K161R are characterised, both in native form 
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and in the presence of the first substrate, pyruvate. It was shown in the previous chapter, 
by using a sodium borohydride inactivation test, that pyruvate does not form a Schiff base 
with either DHDPS-K161A or DHDPS-K161R despite being accepted as a substrate and 
that there is no measurable binding event occurring between the mutant enzymes and 
pyruvate, as assessed by ITC. Therefore, these ligand-bound structures provide further 
insight into which residues are close to this substrate and what structural changes occur in 
the substrate and enzyme upon binding.  
 
I carried out the work in this chapter in the laboratory of Professor Geoff Jameson 
(Massey University, Palmerston North). 
 
 
4.2 Crystallisation and diffraction data collection 
 
Crystals were obtained using the hanging drop-vapour diffusion method as described by 
Mirwaldt et al. (1995)3 but at 12oC. Diffraction data sets were processed and scaled using 
the programme CrystalClear.4 All crystals diffracted to beyond 2.4 Å and they belonged 
to the same space group as the wild-type enzyme, P3121, with minor differences in the 
cell dimensions. The Rmerge values were 0.091, 0.088, 0.139 and 0.114 for DHDPS-
K161A, pyruvate-bound DHDPS-K161A, DHDPS-K161R and pyruvate-bound DHDPS-
K161R, respectively (Table 4.1). 
 
 
4.3 Structure determination and refinement 
 
The structures were solved using the molecular replacement method, as incorporated in 
the programme MolRep,5 based on the structure of the wild-type enzyme found in the 
RCB Protein Data Bank, entry 1YXC. Refinement rounds were performed using 
REFMAC5.5 Electron density maps were interpreted with the aid of COOT. Structure 
quality was assessed using PROCHECK6 and other validation tools in COOT.7 The data 
collected and refinement statistics are shown in Table 4.1.  
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Table 4.1 Data collection and refinement statistics for DHDPS-K161A and DHDPS-
K161R crystal structures with and without pyruvate bound. 
 K161A K161A 
+ pyruvate 
K161R K161R 
+ pyruvate 
Data collection     
Number of crystals 1 1 1 1 
Oscillation range (o) 0.25 0.25 0.20 0.25 
Number of images 361 225 368 494 
Exposure time (sec) 660 570 606 240 
Camera length (mm) 130.1 130.1 130.1 135.2 
Data processing     
Space group P3121 P3121 P3121 P3121 
Unit cella     a, b, c (Å) 121.04, 
121.04, 
110.05 
120.88,    
120.88,    
110.50 
121.02,  
121.02,   
110.95 
121.44,    
121.44,    
111.05 
                    α, β, γ (o) 90, 90, 120 90, 90, 120 90, 90, 120 90, 90, 120 
Resolution (outer shell) (Å) 1.99 
(2.07-1.99) 
2.30 
(2.38-2.30) 
2.40 
(2.48-2.40) 
2.10 
(2.18-2.10) 
Number of reflections 
(unique) 
268,357 
(63,475) 
136,247 
(39,830) 
157,741 
(36,802) 
381,650 
(53,975) 
Completeness (outer shell, %) 99.4 (96.7) 95.0 (97.3) 98.9 (97.4) 97.2 (100) 
I/σ (I) (outer shell) 7.1 (2.3) 7.4 (2.8) 6.5 (2.5) 8.8 (3.3) 
Redundancy (outer shell) 4.23 (4.02) 3.42 (3.27) 4.29 (4.21) 7.07 (7.04) 
Rmergeb (outer shell) 0.091 
(0.453) 
0.088 
(0.350) 
0.139 
(0.454) 
0.114  
(0.443) 
Refinement     
Rfreec (outer shell) 
 
0.2386 
(0.385) 
0.2319 
(0.268) 
0.2344 
(0.336) 
0.2350 
(0.356) 
RCrystd (outer shell) 0.2022  
(0.304) 
0.1845 
(0.254) 
0.2032 
(0.291) 
0.1977 
(0.295) 
Solvent molecules 408 180 208 387 
Glycerol molecules 5 8 3 6 
Pyruvate molecules 0 2 0 2 
Potassium ions 4 4 4 4 
Mean B-value (Å2) 31.53 34.21 28.54 30.89 
root mean square deviation     
           Bond lengths (Å) 0.012 0.023 0.014 0.011 
           Bond angles (o) 1.403 2.006 1.601 1.361 
      a
 Wild-type cell dimensions were a=b=121.87 Å, c=110.19 Å.2 
      b
 Rmerge= Σ |I-‹I›| / Σ‹I›. 
   
 c
 Rfree based on 5% of the total reflections with the same set of reflections transferred from the 
original wild-type structure, common to all four structures. 
      d
 RCryst = Σ(|Fobs|-|Fcalc|) / Σ|Fobs|. 
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4.4 General features of the DHDPS mutants 
 
The final models were made up of two monomers, A and B, with 292 amino acid residues 
each. The tetramer can be generated from these by crystallography symmetry. Each 
monomer is composed of two domains: the N-terminal domain that folds into a (β/α)8 
barrel (residues 1-224) and the C-terminal α-helical domain (residues 225-292) (Figure 
1.2). As described in Chapter one, the active site is found at a cavity formed by the two 
monomers, where the residue at position 161 is found on a hydrophobic scaffold, leaving 
only one side accessible to the solvent (Figures 1.2 and 4.1).  Y133 is positioned directly 
above it and T44 is hydrogen bonded to both Y133 and Y107 (from the adjacent 
monomer in the dimer), forming the catalytic triad. R138 is situated at the entrance of the 
active site cavity, where it is believed to be involved in binding the carboxyl group of (S)-
ASA.8,9 
 
The Rfree values for the final refined structures were: 20.2% for DHDPS-K161A, 18.5% 
for DHDPS-K161A with pyruvate, 20.3% for DHDPS-K161R, and 19.8% for DHDPS-
K161R with pyruvate (Table 4.1). The Ramachandran plot10 for each structure showed 
that all residues fell within favoured regions, except for Y107.  It has been suggested that 
this is the case because its conformational strain is associated with function.2,3,11 
  
The NCS constraints used for all four structures varied from medium, for both the main 
chains and the side chains, for the initial rounds of refinement, to loose for the side chains 
in the later rounds. There was very well defined electron density for the main chain 
residues from the carboxy-terminal to the amino-terminal, except for the N-terminal 
methionine at position 1. The conformation of some side chain residues could not be 
resolved, either because there was no electron density to guide the rebuilding, or because 
the residue appeared to hold several different conformations—these side chains were 
assigned 0% occupancy in the final PDB files.  
 
Overall, the mutant enzymes showed no major changes in their structures when compared 
to the structure of wild-type DHDPS (Figure 4.1), indicating that the attenuated catalytic 
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activities observed in Chapter three were not due to any major structural changes induced 
by the mutations.   
 
 
     A                                                B                     C 
 
 
Figure 4.1 Tertiary structure of the monomer: A, Wild-type DHDPS; B, DHDPS-
K161A; C, DHDPS-K161R. The residue at position 161, found in the centre of the barrel, 
is highlighted in green and blue. The β-sheets are coloured in purple and the α-helices 
are coloured in cyan. This and subsequent figures in this chapter were produced using 
PyMol, unless otherwise stated.12  
 
 
 
 
4.5 Active site of DHDPS-K161A 
 
The structure of DHDPS-K161A showed very well-defined electron density around 
alanine at position 161 (Figure 4.2). The orientation and position of the active site 
residues found in monomer A were very similar to those found in monomer B (Figure 
4.3). The distances between the functional groups of the main active site residues in both 
monomers were also very similar (Table 4.2). Due to the high similarity between the 
monomers within the asymmetric unit, the pictures generated show monomer A only. 
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Figure 4.2 Residue A161 of DHDPS-K161A covered by 2Fo-Fc electron density 
(blue), which is contoured at 1σ.  
 
 
Table 4.2 Comparison of the distance between key groups within the active site of 
wild-type DHDPS and DHDPS-K161A. 
   Wild-typea Monomer A 
DHDPS-K161A 
Monomer B 
DHDPS-K161A 
OH_Y133 NH2_K161 2.9 - - 
OH_Y133 CH3_A161 - 6.7 6.6 
OH_Y133 OH_T44 2.6 3.2 3.3 
OH_T44 OH_Y107 2.6 2.8 2.7 
OH_Y133 OH_107 3.7 4.3 4.5 
OH_Y133 X 2.6 - - 
Protein  
distances 
(Å) 
Nε_R138 X 3.2 - - 
a
 As reported by Dobson et al.2 
 
 
The overlay of the structures of the wild-type enzyme and DHDPS-K161A (rmsd = 0.154 
Å) showed very little change within the active site (Figure 4.4). The conformations of the 
active site residues T45, Y106, Y107, R138, G186 and I203 are completely conserved in 
the structure of this mutant enzyme relative to wild-type DHDPS. Whilst the main chain 
atoms of Y133 are positioned similarly, the aromatic ring was twisted slightly in 
DHDPS-K161A relative to the wild-type enzyme for both subunits A and B. Y133 is 
thought to be central for DHDPS function. It is positioned directly above the residue at 
position 161 and it is part of a hydrogen bond network with T44 and Y107 in the wild-
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type enzyme. This motif makes up the catalytic triad, which facilitates Schiff base 
formation.8,11  
 
 
 
Figure 4.3 Active site residues of monomer A (green) and monomer B (yellow) of 
DHDPS-K161A.  
 
 
The twist in the aromatic ring results in a slightly longer distance between the hydroxyl 
group of Y133 and those of T44 and Y107 compared to the wild-type enzyme (Table 
4.2). Nevertheless, the distance still allows the formation of hydrogen bonds between the 
hydroxyl groups of T44 and Y133 (3.2 Å), and between T44 and Y107 (2.8 Å) as in the 
wild-type, where the distances are both 2.6 Å. This is important because Y133, although 
no longer involved in Schiff base formation in this enzyme, is still presumably involved 
in the binding of the hydrate (S)-ASA.11 This is thought to be achieved by a proton 
transfer to the leaving hydroxyl group.  
 
The larger distance between the T44 and Y133 OH groups can also be accounted for by a 
small movement in the loop bearing T44, which results in a shift of its hydroxyl group 
away from Y133 by approximately 0.2 Å, compared to the wild-type enzyme. 
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Figure 4.4 Overlay of active site of the wild-type DHDPS (yellow) and DHDPS-
K161A (green) from monomer A. X is a water molecule (pink) present in the wild-type 
structure only. Notice the small twist in orientation of the aromatic ring of Y133 and the 
small displacement of T44. 
 
 
An interesting feature of the wild-type structure is the presence of a water molecule 
(Figure 4.4, molecule X) that bridges the hydroxyl group of Y133 (2.6 Å) and the Nε 
atom of R138 (3.2 Å). This water molecule is absent in the structure of this mutant 
enzyme. This water bridges Y133 with the cationic guanidium group of R138, which 
makes the hydroxyl group a better acid. This is particularly important in the first half 
reaction, which involves Schiff base formation, as described in section 1.3.3. When 
absent, as in the wild-type structure with pyruvate bound, the hydroxyl group becomes a 
weaker acid (and perforce a stronger base), which is important in the binding of (S)-
ASA.2 This hypothesis is confirmed by mutagenic experiments, where the change of 
Y133 to a phenylalanine residue increases Km by 100-fold for both pyruvate and (S)-
ASA, whereas the T44V and Y107F mutations only result in Km values that are 
substantially higher with respect to pyruvate.11  
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4.6 Active site of DHDPS-K161R 
 
The crystal structure of DHDPS-K161R confirmed that arginine had successfully been 
introduced at position 161, as evidenced by the well-defined electron density around the 
skeleton of this residue (Figure 4.5). There is no major difference between monomers A 
and B in terms of orientation of residues (Figure 4.6) or distances between the residues 
that make up the catalytic triad (Table 4.3). Therefore, the pictures were generated using 
monomer A only. 
 
 
Figure 4.5 Residue R161 of DHDPS-K161R covered by 2Fo-Fc electron density 
(blue), which is contoured at 1σ.  
 
 
Table 4.3 Comparison of the distance between key groups within the active site of 
wild-type DHDPS and DHDPS-K161R. 
   Wild-typea Monomer A 
DHDPS-K161A 
Monomer B 
DHDPS-K161A 
OH_Y133 NH2_K161  2.9 - - 
OH_Y133 CH3_A161 - 3.4 3.5 
OH_Y133 OH_T44 2.6 3.3 3.4 
OH_T44 OH_Y107 2.6 2.7 2.5 
OH_Y133 OH_107 3.7 4.1 4.1 
OH_Y133 X 2.6 - - 
Protein  
distances 
(Å) 
Nε_R138 X 3.2 - - 
a
 As reported by Dobson et al.2 
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Figure 4.6 Active site residues of monomer A (green) and monomer B (yellow) of 
DHDPS-K161R. 
 
 
The alignment of the asymmetric subunit containing monomers A and B of DHDPS-
K161R and that of the wild-type enzyme resulted in a rmsd of 0.215 Å. There is little re-
organisation of the side chains of the residues in the vicinity of the mutation (Figure 4.7). 
The side chain of R161 adopts a similar fully extended conformation to that of K161 in 
the wild-type enzyme. As in the structure of DHDPS-K161A, the aromatic ring of Y133 
appears to be slightly twisted. T44 has also moved away from Y133 by about 0.5 Å and 
rotated by ~20o, which results in a larger distance between the OH groups of Y133 and 
T44 in both monomers (Table 4.3). These changes are quite significant as the hydrogen 
bond between the hydroxyl groups of T44 and Y133, which are involved in moving 
protons in and out of the active site, is much weaker than in the wild-type enzyme. 
However, the hydroxyl group of Y107 is still positioned similarly and can interact with 
T44 via hydrogen bonds. The remaining residues in the active site are found in the same 
orientation as the wild-type enzyme (Figure 4.7). The water molecule (Figure 4.7, 
molecule X), which connects Y133 and R138 in the wild-type, is also missing in 
DHDPS-K161R. 
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Figure 4.7 Overlay of the active site of wild-type DHDPS (yellow) and DHDPS-
K161R (green) from monomer A. X is a water molecule (pink) present in the wild-type 
structure only. Notice the small twist in orientation of the aromatic ring of Y133 and the 
movement and rotation of T44. 
 
 
4.7 Active site of DHDPS-K161A with pyruvate bound 
 
In order to understand how pyruvate, which is no longer involved in Schiff base 
formation, is binding at the active site of DHDPS-K161A, X-ray data were collected from 
crystals of the protein co-crystallised with pyruvate. Pyruvate was found bound at the 
active site of both subunits, with an occupancy of 50% in subunit A (Figure 4.8) and 
100% in subunit B. A comparison of the pyruvate-bound and pyruvate-free forms of 
DHDPS-K161A reveals that, after pyruvate binding, the structure of the enzyme remains 
predominantly as it was in the pyruvate-free form. Apart from a small rotation of T44 
away from pyruvate upon binding, the remaining active site residues are in the same 
orientation, resulting in a rmsd for the asymmetric unit alignment of 0.176 Å (Figure 4.9). 
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Figure 4.8 2Fo-Fc electron density (blue) contoured at 1σ around pyruvate (cyan) 
and alanine at position 161 (bold and green) at the active site of monomer A of pyruvate-
bound DHDPS-K161A. Note that the occupancy of pyruvate is 50%.  
 
 
 
 
Figure 4.9 Overlay of the monomer A active site of DHDPS-K161A (green) and 
pyruvate-bound DHDPS-K161A (yellow). Pyruvate (PYR) is shown in cyan.  
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4.8 Comparison of the active site of wild-type DHDPS and DHDPS-
K161A with pyruvate bound 
The alignment of the asymmetric unit of wild-type and DHDPS-K161A, both obtained in 
the presence of pyruvate, resulted in a rmsd of 0.187 Å. The structure of the pyruvate-
bound DHDPS-K161A reveals that the free pyruvate has rotated ~90o clockwise from 
where it is found in the wild-type enzyme as part of a Schiff base (Figure 4.10). The 
connections that pyruvate makes to the active site of DHDPS-K161A are shown in Table 
4.4. 
 
Figure 4.10 Comparison of the monomer A active site residues of wild-type DHDPS 
(yellow) and DHDPS-K161A (green) in the presence of pyruvate (PYR), which is shown 
either as part of a Schiff base or in cyan.  
 
 
Table 4.4 Connections and distances between pyruvate and DHDPS-K161A.  
Pyruvate Residue Distance (Å) 
O1 OG1_T45 2.7 
O1 N_T44 3.3 
O2 OG1_Y133 4.1 
O2 Nε_T45 3.0 
O3 - - 
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In the wild-type enzyme, O1 is covalently bound to the amino group of K161 to form the 
Schiff base. In the structure of DHDPS-K161A, the pyruvate molecule has adopted a 
different orientation, where O1 is now oriented towards T44 and T45, allowing 
stabilisation by hydrogen bonds to the backbone amino group of T44 (3.3 Å) and to the 
hydroxyl group of T45 (2.7 Å) (Table 4.4).  
 
In the wild-type enzyme, the O2 and O3 atoms of the carboxylate group of the bound 
pyruvate are oriented toward Y133 (3.3 Å), T44 (2.8 Å) and T45 (2.8 Å). In this mutant, 
the O2 atom is still facing T45 (3.0 Å) but it is too far away from the hydroxyl group 
OG1_Y133 to enable the formation of any hydrogen bonds. The O3 atom of pyruvate is 
now oriented towards the hydrophobic cavity where K161 is usually located and it is not 
in close proximity to any residue or solvent to make hydrogen bond contacts. It is likely 
that this oxygen is protonated. Interestingly, the methyl carbon retains approximately the 
same spatial positioning as in the wild-type enzyme. Figure 4.11 shows all the stabilising 
connections pyruvate makes to the active site residues of DHDPS-K161A. 
 
 
Figure 4.11 Hydrogen bonds stabilising pyruvate (cyan) bound at the active site of 
monomer A of DHDPS-K161A. 
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4.9 Active site of DHDPS-K161R with pyruvate bound 
 
The active sites of both subunits A and B show bound pyruvate molecules, with 
occupancy of 70% in both cases (Figure 4.12). The overlay of the pyruvate-bound and 
pyruvate-free forms of DHDPS-K161R reveals that, apart from a rotation of the loop 
bearing T44 away from pyruvate upon binding, the remaining active site residues are in 
the same orientation as in the pyruvate-free form of the enzyme, resulting in a rmsd for 
the asymmetric unit alignment of 0.168 Å (Figure 4.13). 
 
 
Figure 4.12 2Fo-Fc electron density (blue) contoured at 1σ around pyruvate (cyan) 
and arginine at position 161 (bold and green) at the active site of monomer A of DHDPS-
K161R. Note that the occupancy of pyruvate is 70%. 
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Figure 4.13 Overlay of the active site residues of DHDPS-K161R (green) and 
pyruvate-bound DHDPS-K161R (yellow) from monomer A. Pyruvate (PYR) is shown in 
cyan.  
 
 
4.10 Comparison of the active site of wild-type DHDPS and DHDPS-
K161R with pyruvate bound 
 
The pyruvate bound at each active site of DHDPS-K161R has rotated ~30o clockwise 
from where it binds in DHDPS-K161A. The connections that the pyruvate makes to the 
active site of this mutant enzyme are shown in Table 4.5.  
 
Table 4.5 Connections and distances between pyruvate and DHDPS-K161R.  
Pyruvate Residue Distance (Å) 
O1 OG1_T45 2.1 
O1 NH2_R161 3.3 
O2 N_T44 3.1 
O3 Nε_T45  3.0  
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Figure 4.14 Comparison of the active sites of wild-type DHDPS (yellow) and DHDPS-
K161R (green) from monomer A in the presence of pyruvate (PYR), which is either shown 
as part of the Schiff base or in blue.  
 
 
The O1 atom is now closer to the hydroxyl group of T45 (2.1 Å) than in the other mutant 
structure (2.7 Å), allowing stronger hydrogen bonds to be formed. O1 also makes a strong 
electrostatic interaction with the positively charged amino group of the arginine residue 
introduced at position 161, which is 3.3 Å away. The short distance of pyruvate O1 to 
OG1_T45 and the rather long distance to NH2_R161 could be an artifact of the very 
strong planarity restraints placed on the pyruvate molecule. A small twist about C1-C2 
would lead to a distance of ~2.6 Å to T45. 
 
O2 of the carboxylate group is stabilised by the amino group on the side chain of residue 
T44 (3.1 Å). O3 is the same distance from the backbone amino group of T45 (3.0 Å) as 
O2 is in DHDPS-K161A. The methyl group on pyruvate is facing the hydrophobic cavity 
between R161 and Y133. Figure 4.15 shows all the stabilising connections pyruvate 
makes to the active site residues of DHDPS-K161R. 
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Figure 4.15 Hydrogen bonds stabilising pyruvate (cyan) bound at the active site of 
monomer A of DHDPS-K161R. 
 
 
4.11 Lysine binding site of DHDPS-K161A and DHDPS-K161R 
 
Structurally, the allosteric binding site of both mutants is identical to that of the wild-type 
enzyme (Figure 4.14). Y107 is still solvent accessible to bulk solvent through a number 
of hydrogen bonds to well ordered water molecules leading to the lysine binding site. The 
distance between these water molecules in both mutant enzymes is no more than 3.0 Å.  
 
The aromatic stack formed by Y106 and the Y107 residue from the other monomer, 
which links both active sites to the allosteric binding site, remains intact. It would be 
expected that lysine would bind in a very similar manner to DHDPS-K161A and 
DHDPS-K161R, as observed for wild-type DHDPS. This is entirely consistent with the 
kinetic data obtained in Chapter three. 
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A       B 
Figure 4.14 A Overlay of the lysine binding site of wild-type DHDPS (yellow) 
and DHDPS-K161A (green) from monomer A;  B Overlay of the lysine binding 
site of wild-type DHDPS (yellow) and DHDPS-K161R (green) from monomer A. 
 
 
4.12 Summary 
 
The X-ray crystal structures of both DHDPS-K161A and DHDPS-K161R were solved to 
resolutions of 2.0 and 2.4 Å respectively, and they were compared to the structure of the 
wild-type enzyme solved by Dobson et al. (2005).2 There were no significant changes in 
the tertiary or quaternary structures, including the catalytic and regulatory motifs, upon 
the introduction of the mutations. The mutant enzymes belonged to the same space group 
as the wild-type, P3121, with very similar cell dimensions. This observation confirms that 
the attenuated catalytic activity of the mutant enzymes generated was not due to 
alterations in their structure but due to the absence of the Schiff base-forming residue, 
lysine 161. 
 
The crystal structures of the mutants were also solved with pyruvate bound to resolutions 
of 2.3 and 2.1 Å for DHDPS-K161A and DHDPS-K161R respectively.  These ligated 
structures confirm the inability of the mutant enzymes to form a Schiff base. Free 
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pyruvate is found bound at the active site of both subunits in each enzyme, where it can 
be stabilised by surrounding residues. The allosteric site remains intact for DHDPS-
K161A and DHDPS-K161R.  
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 Chapter Five 
 
Discussion and conclusions 
 
 
 
5.1 Introduction 
 
DHDPS catalyses the first reaction unique to lysine biosynthesis, the condensation of (S)-
ASA with pyruvate to form an unstable heterocyclic molecule, currently believed to be 
HTPA, via a ping-pong mechanism. The major hallmark of this mechanism is the 
formation of a Schiff base intermediate between lysine 161 and the first substrate, 
pyruvate. Although lysine 161 is thought to be the key active site residue in DHDPS, no-
one had yet confirmed this using a site-directed mutagenesis approach. This is probably 
because it was predicted that the enzyme would lose all of its activity upon removal of 
this residue.  
 
The aim of this thesis, as set out in Chapter one, has been to test the assumption that 
lysine 161 is absolutely essential for catalysis by DHDPS. This project was undertaken in 
light of results published by Kruger et al. (2001)1 on a mechanistically and structurally 
related enzyme, NAL, where the mutation of the equivalent residue to an alanine 
completely abolished enzyme activity. 
 
This chapter will discuss the kinetic and structural work presented in Chapters three and 
four and propose a new mechanism for catalysis by DHDPS deprived of lysine 161. The 
results obtained also hint at the evolutionary relationship between DHDPS and NAL.  
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5.2 Significant decrease in catalytic activity for mutants 
 
The kinetic results presented in Chapter three showed that the catalytic activity of both 
mutants was dramatically decreased when compared to the wild-type enzyme. The kcat 
values were decreased by 300–800-fold upon the introduction of an alanine or arginine at 
position 161. These results confirm the importance of lysine 161 in the catalytic 
mechanism of DHDPS. However, the detection of rate enhancements compared to the 
background rate (section 2.5) was unexpected. 
 
The crystal structures of these mutants revealed, firstly, that the desired mutations were 
introduced, and secondly, that no significant changes in the arrangement of the active site 
had occurred. CD spectroscopy showed that the mutations introduced did not alter the 
secondary structure of the mutant enzymes in solution compared to wild-type DHDPS. 
Hence, the dramatic decrease in activity was due to the removal of the Schiff base-
forming residue and not due to gross alterations in the structure of the mutant enzymes.  
 
As mentioned earlier, the mutation of the corresponding lysine residue in NAL to an 
alanine completely abolished activity of the enzyme.1 However, the NAL arginine mutant 
still retained 3% activity. It was proposed that residual activity could be detected because 
the guanidinium group of arginine should still allow the formation of the Schiff base, but 
at a much slower rate than with the amino group of lysine 161. Although arginine has 
been shown to allow Schiff base formation by Morris et al. (1996)2 using sodium 
borohydride to trap this intermediate, no experimental work was conducted by Kruger et 
al. (2001)1 to confirm this proposal. 
 
In this work, treatment of DHDPS-K161A and DHDPS-K161R with the reducing agent 
sodium borohydride and pyruvate did not result in enzyme inactivation, indicating that 
the Schiff base is not formed with either mutant. The crystal structure of the mutant 
enzymes in the presence of pyruvate further confirmed their inability to form a Schiff 
base. Therefore, the activity detected in the DHDPS mutants cannot be attributed to the 
formation of the covalent intermediate. 
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5.3 Binding affinities with substrates 
 
Surprisingly, the mutations did not have a major impact on the ability of the enzyme to 
bind its substrates as judged by the kinetic parameters. The KmPyruvate values (0.45±0.04 
mM for DHDPS-K161A and 0.57±0.06 mM for DHDPS-K161R) increased by only 3-
fold compared to the wild-type enzyme (0.15±0.01 mM). An increase in the Michaelis-
Menten constants with respect to pyruvate was expected since this substrate is no longer 
involved in Schiff base formation. However, the magnitude of the increase was much 
lower than expected for both enzymes. This indicates that other active site residues apart 
from K161 are involved in the initial binding of this substrate, which is observed in the 
crystal contacts made in the wild-type enzyme. 
 
The KmASA value for DHDPS-K161R was identical to that of the wild-type enzyme 
(0.12±0.01 mM), while for the alanine mutant, there was only a 2-fold increase 
(0.23±0.02 mM). This observation agrees with the current proposed mechanism of 
DHDPS, where K161 plays no role in (S)-ASA binding. Assuming that the hydrate of 
(S)-ASA is the relevant species, Y133 is in position to protonate one of the hydroxyl 
groups after the dehydration reaction, while G186 is in position to coordinate the other 
one. The catalytic triad is involved in the stabilisation of the tyrosine anion via a proton 
relay to bulk solvent.3,4  
 
 
5.4 Subtle shift in kinetic mechanism 
 
The statistical values obtained from both the ping-pong and the ternary-complex models 
were very similar for both DHDPS-K161A and DHDPS-K161R. Based on the F-value 
and p-value for each fit, it was decided that the ternary-complex mechanism gave a 
slightly better fit than the classical wild-type ping-pong mechanism. In the ping-pong 
mechanism, the substrates bind in a defined order via a covalently bound enzyme-
substrate intermediate and two independent products are released.5 In the case of wild-
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type DHDPS, water is released as the first product of the reaction mechanism upon 
formation of the enamine, before (S)-ASA can bind.  
 
For the mutants generated in this work, both substrates can be present simultaneously at 
the active site prior to product formation. This is not surprising since these enzymes are 
unable to form a Schiff base and consequently, unable to release water as the first 
product. 
 
 
5.5 Schiff base enhances stability of wild-type DHDPS 
 
It has been suggested that DHDPS is stabilised by its first substrate, pyruvate.6 This 
anecdotal observation was confirmed during this work using differential scanning 
fluorimetry. The addition of saturating concentrations of pyruvate to wild-type DHDPS 
resulted in a 9.9oC increase in the melting temperature (Tm). This increase in stability was 
hypothesised to be attributed to a tighter protein packing upon the formation of the Schiff 
base.  
 
The Tm values of the mutants with pyruvate only increased by ~2oC, showing that the 
stabilisation of DHDPS by pyruvate is largely, but not entirely, dependent on Schiff base 
formation. This is further confirmed by an increase in the B-values from the crystal 
structures upon binding of pyruvate in both DHDPS-K161A (31.53 Å2 compared to 34.21 
Å2 in the presence of pyruvate) and DHDPS-K161R (28.54 Å2 compared to 30.89 Å2). 
The mean B-value for wild-type DHDPS in the presence of pyruvate remains exactly the 
same as in the pyruvate-free form (19.9 Å2). However, the lower resolutions of the crystal 
structures obtained in this work, compared to that of the wild-type enzyme, could account 
for some of the differences in the B-values. 
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5.6 Lysine 161 is not involved in the regulatory mechanism 
 
Evidence from kinetic and structural studies have supported the idea that lysine is an 
allosteric inhibitor of wild-type DHDPS;3,7-9 however, the exact mechanism by which 
lysine exerts its regulatory effect is still open to debate.  
 
Both DHDPS-K161A and DHDPS-K161R showed very similar behaviour in relation to 
lysine sensitivity when compared to the wild-type: at saturating concentrations of the 
inhibitor, the mutant enzymes were still 7-10% active and they displayed the same type of 
inhibition. There was also little change in their Ki values. The structure of the lysine 
binding site of the mutants is identical to that of the wild-type. The aromatic stack formed 
by Y106 and the Y107 residue from the other monomer, which links both active sites to 
the allosteric binding site, remains intact. It would be expected that lysine would bind in a 
very similar manner to DHDPS-K161A and DHDPS-K161R as observed for wild-type 
DHDPS. It is clear from the kinetic and structural studies presented in this work that 
lysine 161 is not involved in the regulatory mechanism of DHDPS. 
 
 
5.7 Binding of pyruvate 
 
The mutation of the nucleophilic lysine 161 residue had significant consequences for 
DHDPS activity by precluding the formation of the covalent intermediate, which is an 
important step in the catalytic mechanism. Nevertheless, the detection of residual activity 
suggests that pyruvate is still binding and interacting with other residues, since 
considerable rate enhancement compared to the background rate is observed when (S)-
ASA and pyruvate are mixed together in the presence of both K161 mutant enzymes. 
This emphasises the idea that enzymes lacking key catalytic groups are still good 
catalysts.10 Similar residual activities were observed when Y133 and T44, which are part 
of the catalytic triad of DHDPS, were mutated to a phenylalanine and a valine 
respectively.4 The slight increase in stability of the mutant enzymes upon addition of 
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pyruvate observed in the DSF experiments also demonstrates that pyruvate is still binding 
to these enzymes, despite their inability to form a Schiff base. 
The structure of DHDPS-K161A and DHDPS-K161R that had been co-crystallised with 
pyruvate revealed that one free pyruvate molecule binds at each active site of both 
enzymes. Obviously, the position of the pyruvate molecules is different from that found 
in the wild-type enzyme, since this substrate is no longer part of a Schiff base. 
Nevertheless, each enzyme still retained a well defined binding site for pyruvate that is 
not dependent on lysine 161. The structure of the pyruvate-bound DHDPS-K161A 
reveals that the free pyruvate has rotated ~90o clockwise from its orientation in the wild-
type enzyme. Pyruvate is located near the amide N_T44, Nε_T45 and the hydroxyl group 
OG1_T45, at hydrogen-bonding distances of 3.3 Å, 3.0 Å and 2.7 Å, respectively. The 
pyruvate is bound at each active site of DHDPS-K161R in a slightly different orientation 
from where it binds in DHDPS-K161A. However, pyruvate is still stabilised by the same 
groups: N_T44 (3.1 Å), Nε_T45 (3.0 Å) and OG1_T45 (2.1 Å). In addition, it makes a 
strong electrostatic interaction with the positively charged guanidinium group of the 
arginine residue introduced at position 161, which is 3.3 Å away. This additional 
electrostatic interaction could explain why the arginine mutant was found to have a 
slightly higher catalytic activity than the alanine mutant. 
A comparison of the pyruvate-bound and pyruvate-free forms of the mutant enzymes 
reveals that, after pyruvate binding, the active site residues remain predominantly as they 
were in the pyruvate-free form. The main change observed is the small movement of the 
loop bearing T44 away from pyruvate upon binding in both enzymes, which is also 
observed in the wild-type enzyme. The lack of heat production associated with the 
binding of pyruvate to the mutant enzymes observed in the ITC experiments is consistent 
with the lack of conformational change upon pyruvate binding. Pyruvate is held at the 
active site in the mutant enzymes through favourable electrostatic interactions, which are 
much weaker than the covalent bond that is formed in the wild-type enzyme. It is likely 
that the energy released when pyruvate binds is offset by the energy required to move 
solvent molecules out of the active site in order to accommodate this substrate. 
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5.8 Alternative mechanism  
 
The existence of a covalent intermediate between pyruvate and the active site lysine 161 
residue has been shown by trapping the intermediate with sodium borohydride,11 by 
electrospray ionisation mass spectrometry,12 and by X-ray crystallography.3 However, 
site-directed mutagenesis had not been employed to confirm this. It can be concluded 
from the kinetic and structural data gathered for DHDPS-K161A and DHDPS-K161R, 
that although lysine 161 is important for catalysis, it is not absolutely essential. The 
current proposed catalytic mechanism must therefore be reconsidered and expanded. 
 
There are a number of mechanisms that can be employed by enzymes to lower the free 
energy of activation of a reaction. Such mechanisms include electrostatic and geometric 
complementarity to the transition state in order to reduce the enthalpy of transition state 
formation, and the use of binding energy for precise positioning of the substrates for 
lowering the entropy of activation.13  It has been shown that by simply bringing substrates 
together and correctly positioning two reactants in an enzyme active site, a rate 
enhancement of up to 108-fold compared to 1 M reactants in free solution can be 
achieved.14 
 
It is hard to understand how an enzyme that employs a ping-pong mechanism can still 
function without its catalytic nucleophile. This is because a ping-pong mechanism 
implies that the first half of the reaction, which in this case involves pyruvate binding and 
Schiff base formation, must be completed before the binding of the second substrate. 
Thus, an enzyme variant lacking a nucleophile necessary for its original activity may 
catalyse a different chemical transformation by using a mechanism that had previously 
been superseded by the nucleophilic attack on the substrate.15 
 
In the current proposed mechanism, the tautomerisation of the Schiff base to an enamine 
species creates the nucleophile that attacks (S)-ASA. This is followed by cyclisation, 
which leads to the release of HTPA from the active site (Figure 1.3). Since the Schiff 
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base is no longer being formed with these mutant enzymes, another nucleophilic species 
must be present that can still react with the second substrate.  
 
Here, it is proposed that the enol form of pyruvate, which exists in equilibrium with its 
keto tautomer, can fulfill the role of the enamine species (Figure 5.1). Enols are the 
oxygen analogues of enamines, but their formation from ketones is less 
thermodynamically favourable than enamine formation from Schiff bases.16 NMR studies 
from Chapter three suggest that the rate of enolisation of the keto form of pyruvate to its 
enol tautomer is unchanged in DHDPS-K161A and DHDPS-K161R catalysed 
mechanism, ruling out the possibility that the enolisation process could be the rate-
determining step. ITC experiments show that in the absence of Schiff base formation, 
enthalpic contributions may not be responsible for the observed enzymatically 
accelerated reaction of these two substrates as no measurable binding event occurs 
between the mutant enzymes and pyruvate. It is likely that substrate orientation and 
favourable charge interactions may facilitate interaction of an active site bound pyruvate 
with (S)-ASA and may be the major catalytic devices operating in DHDPS-K161A and 
DHDPS-K161R. Future work should investigate this mechanism further, perhaps using 
labelled substrates and monitoring kinetic isotope effects to explore the rate-determining 
step. 
 
It is proposed that for DHDPS-K161A and DHDPS-K161R, the oxygen atom on the enol 
is stabilised by the hydrogen bond contact it makes with the hydroxyl group of T45 in 
both enzymes. The carboxylate is stabilised primarily by the backbone amino group of 
T44. The binding of (S)-ASA and subsequent cyclisation and product release is proposed 
to occur in exactly the same fashion as in wild-type DHDPS. Y133 in both DHDPS-
K161A and DHDPS-K161R are in a similar position as in the wild-type enzyme, despite 
being slightly twisted. This allows this residue to still be able to protonate one of the 
hydroxyl groups of (S)-ASA, while G186, whose position is in both mutant enzymes is 
exactly the same as in wild-type DHDPS, can still coordinate to the other hydroxyl group.  
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Figure 5.1 Proposed mechanism for how DHDPS lacking lysine 161 catalyses the 
condensation reaction between (S)-ASA and pyruvate to form HTPA.  
 
 
The crystal structures showed that T44 moved away from Y133 in both mutant enzymes, 
resulting in a larger distance (an increase of ~0.6 Å) between the OH groups of Y133 and 
T44. The distance, however, is still small enough to allow the formation of a hydrogen 
bond between the hydroxyl groups of these residues, which are involved in moving 
protons in and out of the active site. The hydroxyl group of Y107 is still positioned 
similarly in both mutant enzymes and can interact with T44 via hydrogen bonds. So it is 
likely that the catalytic triad is still operating in DHDPS-K161A and DHDPS-K161R by 
stabilising the tyrosine anion via a proton relay to bulk-solvent. Y133 is also still believed 
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to be involved in coordinating the attacking amine group in this alternative mechanism, 
which facilitates cyclisation and product release. 
 
The ternary-complex mechanism can operate in an ordered or random fashion in terms of 
substrate binding.5 Unfortunately, this can not be determined by looking at the kinetic 
data alone. So even though the scheme outlined in Figure 5.1 shows pyruvate binding at 
the active site first, it is possible that (S)-ASA is the first substrate to bind. 
 
The detection of residual activity in site-directed mutants of enzymes from other families, 
which lack their key active site residue, has been observed in many cases14,17-19 This 
suggests that it is not uncommon for enzymes to use more than one mechanism to 
enhance their rate of reactions. Removal of the Schiff base-forming residue in DHDPS 
could not impede catalysis completely because of the existence of a ‘back-up’ 
mechanism, in which lysine 161 plays no part. This ‘back-up’ mechanism seems not to be 
present in the NAL enzyme, where mutation of the equivalent residue to an alanine 
abolished all activity.  
 
 
5.9 Evolutionary relationship between DHDPS and NAL 
 
DHDPS belongs to a sub-family of the (α/β)8 proteins, whose members also include 
NAL, trans-o-hydroxybenzylidenepyruvate hydratase-aldolase (HBPHA), D-5-keto-4-
deoxyglucarate  dehydratase (DOGDH), trans-2’-carboxybenzalpyruvate hydratase-
aldolase (CBPHA) and D-2-keto-3-deoxygluconate aldolases (KDGA). The MosA 
protein is also thought to belong to this sub-family.20 These enzymes all share common 
structural features but they catalyse different reactions on separate biochemical 
pathways.21 It has been proposed that these enzymes share a unifying step in their 
reaction pathway, namely the Schiff base formation between a strictly conserved lysine 
residue and the C2 carbon of the common α-keto acid moiety of the substrate.20 
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Out of the seven members, only DHDPS and NAL have been well-characterised in terms 
of function and structure. The crystal structures of both of these enzymes have been 
determined for a range of organisms.3,20,22-24 NAL and DHDPS show the hallmarks of an 
enzyme sub-family: a low level of sequence identity (<24% between the two E. coli 
enzymes), but a similar fold with similar active site architecture.25 In particular, sequence 
alignments indicates that the Schiff base-forming residue (K161), as well as the other 
active site residues (T44, T45, Y133, G186, Y107 and I203), have the same spatial 
positioning. This led to the conclusion that the mechanism of Schiff base formation and 
the subsequent aldol reaction is likely to be conserved in both enzymes.3  
 
The results in this thesis give further insights into the evolutionary relationship between 
NAL and DHDPS. The NAL-K161A enzyme was completely inactive but the DHDPS-
K161A enzyme still retains some activity. Based on these results and the central 
metabolic role of DHDPS, it is reasonable to speculate that DHDPS evolved before NAL. 
The ancestral form of DHDPS probably lacked the lysine 161 residue and performed 
catalysis through the alternative mechanism proposed in this thesis, where orientation and 
non-covalent substrate binding are major catalytic devices (Figure 5.2). On the other 
hand, NAL activity evolved after the appearance of the Schiff base-forming residue, 
which facilitates catalysis because it is more nucleophilic than the enol form of pyruvate. 
These results may thus provide fresh insights into the mechanism and evolution of 
enzymatic activities of other class I aldolases. 
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Figure 5.2 Proposed evolution of enzymatic activity in the DHDPS sub-family. 
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5.10 Summary 
Site-directed mutagenesis confirmed the involvement of lysine 161 in DHDPS Schiff 
base formation.  Nevertheless, the mutant enzymes still displayed residual activities, 
implying that Schiff base formation is not absolutely essential for DHDPS activity. 
DHDPS deprived of lysine 161 can still catalyse the condensation reaction between (S)-
ASA and pyruvate, using orientation and proximity as major catalytic devices. Such 
results underscore the sophistication of enzyme catalysis and the functional plasticity of 
enzyme active sites.  
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Chapter Six 
 
Experimental 
 
 
6.1  Materials 
 
Chemicals were purchased, unless otherwise stated, from Sigma-Aldrich (Castle Hill, 
Australia). Media for bacterial cultures and SDS-PAGE gels were purchased from 
Invitrogen (Christchurch, New Zealand). Bio-Rad protein assay kit and DNA ladders 
were purchased from Bio-Rad Laboratories (Auckland, New Zealand). Column 
chromatography media were purchased from GE Healthcare (Auckland, New Zealand) as 
Hi-Trap pre-packed columns or as a loose gel. 
 
pH measurements were made using a standard pH meter with a Russell combination (Tris 
compatible) electrode type number TR/CMAW711/TB. 
 
Sonication was performed using a Sonics Vibra Cell sonicator (50 Watts, 4 minutes total 
on, pulsing 2 seconds on, 9.9 seconds off). 
 
Centrifugation was performed in an Eppendorf centrifuge 5430, on a small scale (less 
than 1.5 mL) at up to 14000 rpm using a F45-30-11 rotor, and on a large scale (less than 
50 mL) at up to 4000 rpm using an A-4-81 rotor at 4oC. 
 
Columns were run using the GE Healthcare ÄKTA process system with UNICORN 
software control and a GE Healthcare Frac-950 fraction collector. 
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Polyacrylamide gel electrophoresis (PAGE) was run on an Invitrogen electrophoresis 
unit, using an Invitrogen power pack. 
 
Ultraviolet (UV) spectroscopy was performed on a Hewlett Packard 8452A diode array 
spectrophotometer with a circulating water bath to maintain a constant temperature. 
 
Far –UV circular dichroism spectra were recorded from 200 nm to 250 nm at 20oC using 
a Jasco CD J-185 spectrophotometer. 
 
Differential scanning fluorimetry was done using the iCycler iQ Real Time PCR 
detection system from Bio-Rad. 
 
1H NMR spectra were recorded on a Varian INOVA 500 spectrometer, operating at 500 
MHz and temperature regulated at 23°C. A PRESAT solvent suppression algorithm was 
used to moderate the HOD solvent peak at 4.65 ppm. Samples were referenced to t-
butanol as an internal standard.  
 
Protein crystallisation was performed with equipment supplied by Hampton Research. 
Intensity data were collected at 110 Kelvin using an R-AXIS IV++ image-plate detector 
coupled to a Rigaku Micromax 007 X-ray generator, operating at 40 kV and 20 mA. 
 
 
6.2  Molecular biology and microbiology techniques 
 
The methods found in this section were based on protocols in “Molecular cloning: a 
laboratory manual” by Sambrook et al. (1990).1 
 
6.2.1 Strains and plasmids 
The two strains used in this work were E. coli XL-1 Blue (Strategene) and E. coli AT997 
recA- (dapA-, Tetr). 
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The plasmids used (Table 6.1) were based on the vector pBluescript KS+ and pETM11. 
The gene dapA encodes dihydrodipicolinate synthase and dapB encodes 
dihydrodipicolinate reductase. 
 
Table 6.1 Plasmids used for protein expression and their genotypes. 
Plasmids Relevant genotype 
pJG001 :: dapA, Ampr 
pSD002 :: dapB, Kanr 
pTC-K161A :: dapA-lys161ala, Ampr 
pTC-K161R :: dapA-lys161arg, Ampr 
 
 
6.2.2 Bacterial cultures 
The cultures were grown under sterile conditions and were transferred in a laminar flow 
hood. All media and equipment were bought sterile or autoclaved at 121oC for 20 min. 
Solutions were prepared in sterile distilled water. Standard sterile techniques were used in 
all manipulations of bacterial cultures and each experiment included a set of controls to 
detect any contamination. 
 
6.2.3 Media 
Luria-Bertani medium (LB) LB base was supplied by Invitrogen in a ready to use 
powdered form.  To a litre of water, 20 g of LB base was added.  The pH was then 
adjusted to 7 by addition of NaOH, and the resulting medium was sterilised by autoclave. 
 
NZY+ broth To a litre of water, 10 g of NZ amine, 5 g of yeast extract and 5 g of NaCl 
were added.  The pH was adjusted to 7 by addition of NaOH, and the medium was 
autoclaved.  Following autoclaving, filter-sterilised MgCl2 (1 M, 12.5 mL), MgSO4 (1 M, 
12.5 mL), and glucose (20%, 20 mL) were added. 
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SOC The following were added to dH20 (to a final concentration): bactotryptone (2% 
w/v), yeast extract (0.5% w/v), NaCl (10 mM), KCl (2.5 mM), MgCl2 (10 mM), MgSO4 
(10 mM), and glucose (36% w/v).  The resulting medium was then autoclaved. 
 
6.2.4 Antibiotics and nutritional supplements 
Stock solutions of antibiotics and supplements (1000x) were sterilised by filtration, where 
required, and stored at -20oC.  The final concentrations used for selection are shown in 
Table 6.2. 
 
Table 6.2 Concentration of supplements used for bacterial selection.  
Supplement [Stock] mg mL-1 [Working] µg mL-1 
Ampicillin 100 100 
Tetracycline 25 25 
meso-Diaminopimelate 10 50 
 
 
6.2.5 Plate preparation 
For every 1 mL of molten LB media, 1 µL of antibiotic and 5 µL of meso-
diaminopimelate were supplemented.  The resulting medium was poured directly into 
sterile petri dishes close to a flame. The plates were then flamed to get rid of any bubbles 
formed before they had hardened. The plates were placed in a laminar flow hood to 
remove condensation and once dry, they were ready for use. 
 
6.2.6 Colony growth 
Agar plates were streaked with E. coli (from a glycerol freeze, an overnight culture, or a 
single colony on an agar plate) using a flamed sterilised nichrome wire.  The plates were 
incubated overnight at 37oC.  Single colonies were selected and used to inoculate LB 
liquid medium (10 mL).  Starter cultures were grown overnight in a shaker incubator 
(37oC, 180 rpm) and subsequently used to inoculate larger quantities of media. 
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6.2.7 Preparation of glycerol freeze stocks for storage 
An aliquot (1.5 mL) from an overnight culture was centrifuged (14.5 rpm for 3 min).  The 
pellet was re-suspended in 750 µL of the cells, followed by addition of glycerol (sterile 
50% v/v, 500 µL).  The stock was vortexed before being frozen and stored at -80oC. 
 
6.2.8 Competent cell preparation and transformation of AT997recA- by 
electroporation 
An overnight culture was inoculated with a single colony of E. coli from an agar plate, 
and the culture was incubated at 37oC overnight. This inoculum was used to seed 1 L of 
media, which was grown until A600 = 0.8. The culture was chilled on ice for 15 min and 
then centrifuged in cold rotor (4000 g at 4oC for 15 min). The pellet was re-suspended in 
cold water (1 L) and centrifuged as before. The pellet was washed with cold sterile water 
(500 µL) and centrifuged again. The latter step was repeated once more. A final wash 
was performed with glycerol/water (20 mL, sterile, 10% v/v) and the cells were collected 
by centrifugation. The resulting pellet was re-suspended in 3 mL of cold glycerol/water 
(10% v/v), from which 40 µL aliquots were stored at -80oC. 
 
When required, competent cells were removed from the freezer and defrosted on ice prior 
to electroporation. Plasmid DNA (2 µL) in low ionic strength buffer was added to the 
cells before placed in a pre-chilled cuvette. 
 
Electroporation was performed on a Bio-Rad Gene Pulser set to 2.5 kV at 25 µF with the 
pulse controller set at 200 Ω. After pulsing, 1 mL of cold SOC was added immediately to 
re-suspend the cells. The cells were then transferred to an Eppendorf and incubated at 
37oC with gentle shaking (100 rpm for 1 hour). Transformants were spread on LB agar 
plates, with the appropriate antibiotics and supplements, and incubated overnight. 
 
6.2.9 Standard plasmid preparation by alkaline lysis 
 
Solution one  50 mM glucose, 10 mM EDTA, 25 mM Tris.HCl (pH 8.0) 
Solution two  0.2 M sodium hydroxide, 1% (w/v) SDS  
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Solution three  3 M sodium acetate (pH 4.8), 11.5% (w/v) glacial acetic acid  
 
A single bacterial colony was used to inoculate LB broth (10 mL) with appropriate 
antibiotics and nutrients and incubated overnight (37oC, 180 rpm). An aliquot (1.5 mL) of 
the culture was added into an Eppendorf and centrifuged (14000 g at 4oC for 30 s). The 
supernatant was discarded and the bacterial pellet was re-suspended in ice-cold solution 
one (100 µL) by vigorous vortexing. Freshly prepared solution two was added, mixed 
with gentle inversion and chilled on ice (5 min). Ice-cold solution three was added, the 
solution was vortexed gently, and the tube was chilled on ice (5 min). The tube was 
centrifuged (14000 g at 4oC for 5 min) and the supernatant was transferred to a fresh tube.  
 
The double stranded DNA in solution was precipitated with ethanol (900 µL) at room 
temperature and mixed by vortexing. The mixture was allowed to stand at room 
temperature (2 min) and centrifuged once more (14000 g at 4oC for 5 min). The pellet 
was rinsed with ethanol (70%, 1 mL at 4oC), centrifuged (14000 g at 4oC for 5 min) and 
the supernatant was removed. The pellet of DNA was allowed to dry in the air (10 min), 
re-dissolved in water (30 µL) and stored at -80 oC. 
 
6.2.10 PCR site-directed mutagenesis 
The Stratagene QuikChange site-directed mutagenesis kit2 was used to introduce the 
mutations. 
 
Primer design 
Complementary primers were designed to introduce the specific amino acid mutations 
into the DHDPS gene. The primers were 42 bases in length with a minimum GC content 
of 40% and terminated in one or more CG bases. The melting temperature (Tm) was 
required to be greater than 78oC. Equation (6.1) was used to estimate the melting 
temperature of the primer. 
 
Equation (6.1)2 Tm = 81.5 + 0.41(%GC) – 675/N - % mismatch 
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Where N is the primer length in base pairs. As an example, the lysine to alanine mutation 
is illustrated. The dapA sequence, either side of K161 (highlighted in bold), is shown in 
the following page. 
 
5’
 G GCG AAA GTA AAA AAT ATT ATC GGA ATC AUA GAG GCA ACA GGG 3’ 
                                                                                           K161 
 
The generation of the amino acid change lysine to alanine required a single mutation 
from AUA to GCA. Thus the primers were: 
 
Primer 1 
5’
 G GCG AAA GTA AAA AAT ATT ATC GGA ATC GCA GAG GCA ACA GGG 3’ 
 (28) K161 (12) 
 
Primer 2 
3’
 C CGC TTT CAT TTT TTA TAA TAG CCT TAG CGT CTC CGT TGT CCC5’ 
 (28) K161 (12) 
 
Primers were from Invitrogen and they were purified using polyacrylamide gel 
electrophoresis (PAGE). 
 
PCR conditions 
The template DNA, pJG001, was diluted to two concentrations, 0.5 ng/µL and 5 ng/µL 
and the primers were diluted with dH2O to 10 ng/µL (Table 6.3). The reversion mutation 
of pWhitescript with the primers designed was used as a control because this plasmid has 
a point mutation in the lacZ’ gene (β-galactosidase), generating a stop codon at position 
nine of the coding region. The mutagenic primers should replace the stop codon with a 
glutamine codon, thus restoring activity of the enzyme. The efficiency of the mutations 
was determined by the proportion of blue/white colonies on IPTG/X-Gal LB plates. 
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Table 6.3 Concentration of reagents used for mutagenesis reactions.  
Reagent  
(Stock concentration) 
Control reaction 
 (Final amount) 
Sample reaction  
1 (Final amount) 
Sample reaction 
2 (Final amount) 
10x reaction buffer 5 µL 5 µL 5 µL 
pWhitescript 4.5 kb 
control plasmid (5 ng/ µL) 
2 µL 
(10 ng) 
- - 
Oligonucleotide control 
primer#1 34-mer 
1.25 µL  
(125 ng) 
- - 
Oligonucleotide control 
primer#2 34-mer 
1.25 µL  
(125 ng) 
- - 
dsDNA template  
(0.5 ng/ µL) 
- 10 µL  
(5 ng) 
- 
dsDNA template  
(5 ng/ µL) 
- - 10 µL  
(50 ng) 
Oligonucleotide primer 1  
(10 ng/ µL) 
- 12.5 µL  
(125 ng) 
12.5 µL  
(125 ng) 
Oligonucleotide primer 2  
(10 ng/ µL) 
- 12.5 µL  
(125 ng) 
12.5 µL  
(125 ng) 
dNTP mix 1 µL 1 µL 1 µL 
dH2O 38.5 µL 8 µL 8 µL 
Pfu Turbo DNA 
polymerase (2.5 / µL) 
1 µL 1 µL 1 µL 
 
 
Once the PCR steps described in Table 6.4 were completed, the amplification of the 
parental plasmid was verified by running an agarose gel electrophoresis using the 
equivalent amount of starting template DNA as a control. 
 
Template digestion 
In order to digest methylated parental DNA, endonuclease enzyme DpnI (1 µL, 10 Units 
µL-1) was added to the reaction products, mixed, centrifuged, and incubated at 37oC for 1 
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hour. DpnI digests parental (non-mutated) supercoiled dsDNA, leaving newly synthesised 
DNA unaffected. 
 
Table 6.4 PCR cycling parameters for mutagenesis reaction. 
Control reaction Sample reaction 
Step Temperature 
(oC) 
Time (min) Step Temperature 
(oC) 
Time (min) 
1 95 0.5 1 95 0.5 
2 95 0.5 2 95 0.5 
3 55 1 3 55 1 
4 68 12 4 68 12 
5 Steps 2-4 eleven times 5 Steps 2-4 eleven times 
 
DNA sequencing 
DNA sequencing reactions were performed at the Auckland Genomics Facility. Plasmids 
to be sequenced were quantified using a spectrophotometer and sequenced using the 
dideoxynucleic acid chain termination method, using the IR-labelled primers T3 and T7. 
 
6.2.11 Agarose gel electrophoresis 
 
Loading dye 30% (v/v) glycerol, 0.25% (w/v) bromophenol blue, 0.25% (w/v) 
xylene cyanol  
 
TAE buffer  40 mM Tris-acetate (pH 8.0), 1 mM EDTA  
 
The gel (TAE buffer 30 mL, agarose 0.3 g) was cooled to ~50oC, poured into a gel 
casting tray, and the well comb inserted. The comb was only removed when the gel had 
set completely. The casting tray was transferred into a gel tank containing electrophoresis 
TAE buffer.  The gel was loaded with DNA (1 µL), which had been mixed with loading 
buffer (1 µL), along with a DNA ladder. The gel was run at 60 V for ~2 hours. The gel 
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was stained with ethidium bromide (0.5 mgmL-1, 20 min) and the DNA fragments were 
visualized under UV radiation (302 nm). 
 
 
6.3   Biochemistry techniques 
 
Unless otherwise stated, enzymes were manipulated on ice or at 4oC to reduce 
denaturation. All enzymes were routinely stored in 20 mM Tris.HCl pH 8.0 at 4oC (buffer 
A) at -20oC in 1 mL aliquots. 
 
6.3.1 Preparation of the crude 
The cultures incubated overnight were placed on ice (20 min), and the cells were 
harvested by centrifugation (4000 rpm at 4oC for 10 min) and re-suspended in buffer A. 
The cells were sonicated (20 min) to release protein and centrifuged (4000 rpm at 4oC for 
20 min). The supernatant (crude) was either stored at -20oC or applied to a column for 
purification. 
 
6.3.2 Purification of DHDPR  
Affinity chromatography 
The crude was loaded onto a His-Trap column. The column was washed with an 
extraction buffer (50 mM NaH2PO4, pH 8.0, 50 mM imidazole, 300 mM NaCl) for 3 
column volumes and then protein was eluted with elution buffer (50 mM NaH2PO4, pH 
8.0, 500 mM imidazole, 300 mM NaCl). Fractions containing DHDPR activity were 
pooled, dialysed against buffer A and stored at -20o C. 
 
6.3.3 Purification of DHDPS  
Heat shock 
Aliquots of the crude (1 mL) were added to centrifuge tubes, heat shocked at 70oC for 2 
min. The tubes were immediately cooled on ice before centrifugation (14000 rpm at 4oC 
for 10 min). The supernatants were collected and pooled. 
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Ion exchange chromatography 
The pooled sample from heat shock was loaded onto a Q-Sepharose column (bed volume 
75 mL, 15 x 2.6 cm) that had been pre-equilibrated with 5 bed volumes of buffer A. The 
column was then washed with 5 bed volumes of the same buffer and the enzyme was 
eluted with a 0-1 M NaCl gradient in buffer A. The column was washed with three bed 
volumes of the regeneration buffer (1 M NaCl in buffer A). Eluted fractions were tested 
for DHDPS activity using the o-aminobenzaldehyde assay (Table 6.5). 
 
Table 6.5 Reagents used in o-aminobenzaldehyde assay. 
 [Initial] mM Volume µL [Final] mM 
Tris.HCl pH 8.0 at 25oC, pyruvate 200,40 150 166,33 
o-aminobenzaldehyde 400 5 10 
DHDPS test solution - 5 - 
(S)-ASA 40 5  
Total volume  165  
 
The assay mix was incubated (30oC for 30 min) and the reaction was quenched by the 
addition of TCA (10%, 100 µL). Active fractions showed purple coloration and were 
pooled. Control assays without substrate or enzyme were also prepared. 
 
Hydrophobic interaction chromatography 
Ammonium sulfate was added to the pooled fractions from the ion exchange step to a 
concentration of 0.5 M. This was loaded onto a phenyl-Sepharose column (bed volume 
25 mL, 7 x 2.6 cm) that had been pre-equilibrated with five bed volumes of 0.5 M 
ammonium sulfate in buffer A. The column was then washed with five bed volumes of 
the start buffer (0.5 M ammonium sulfate, buffer A) and the enzyme was eluted with an 
ammonium sulfate gradient (0.5-0 M) in buffer A. The column was washed with three 
bed volumes of buffer A. Eluted fractions were tested for DHDPS activity using the o-
aminobenzaldehyde assay described earlier in this section. 
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Size exclusion chromatography 
The pooled sample from hydrophobic interaction chromatography was loaded onto a size 
exclusion chromatography column that had been pre-equilibrated with five bed volumes 
of buffer A. The fractions were once again tested for DHDPS activity using the o-
aminobenzaldehyde assay. 
 
6.3.4 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
 
Table 6.6 Sample preparation for SDS-PAGE. 
Reagent Volume (µL) 
Sample x 
NuPAGE® LDS sample buffer (4X) 2.5 
NuPAGE® reducing agent (10X) 1 
dH20 To 6.5 
Total volume 10 
 
Electrophoresis tank buffer  NuPAGE ® MOPS SDS running buffer (Invitrogen) 
Coomassie blue stain 1% (w/v) Coomassie blue, 50% (v/v) methanol, 
10% (v/v) glacial acetic acid  
Destain 5% (v/v) methanol, 10% (v/v) glacial acetic acid  
 
Pre-cast 4-12% gradient gels were used for analysis. Samples had to be diluted with 
buffer to allow the loading of ~20 µg of total protein, and then mixed with equal volume 
of sample treatment buffer. Samples were heat shocked at 70oC for 10 min before being 
loaded into the wells of the gel. The gel was run at 200 V for 50 min and it was stained 
with Coomassie blue for 30 min, followed by destaining. 
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6.3.5 Bradford assay  
Protein concentration was determined using the standard Bradford procedure (Table 
6.7).3 The samples were diluted to give absorbance readings at 595 nm between 0.1 and 
1.0. 
 
Table 6.7 Volume of solutions used for the Bradford assay 
Assay solutions Volume (µL) 
Sample 80 
H2O 720 
Bio-Rad protein solution dye  200 
 
The assays were incubated at room temperature for exactly 10 min before measuring the 
absorbance at 595 nm, blanked against a solution containing 800 µL dH2O and 200 µL of 
Bio-Rad solution. Each measurement was performed in triplicate. The protein 
concentrations were obtained from a calibration curve generated in parallel using BSA. 
 
6.3.6 Kinetic studies of DHDPS  
All components shown in Table 6.8, except the test solution, were added to the cuvette 
and incubated at 30oC for 15 min. The test solution was added with quick mixing using 
the pipette tip after the incubation period. The change in absorbance at 340 nm was 
recorded over 60 seconds, blanked against water. Controls against no substrate, and 
controls lacking DHDPS were also carried out.  This method was adapted from Coulter et 
al. (1999)4 and Dobson (2003).5  
 
Data analysis 
The initial rate data collected were analysed using the Enzfitter programme available 
from Biosoft (Cambridge, UK). The models used to fit the data were chosen based on R2 
values and the lowest standard errors associated with the fit. When these parameters were 
similar, the model was chosen based on the lowest F- and p-values. 
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Table 6.8 Coupled assay to measure the initial rate of DHDPS-catalysed reaction.5 
Stock [stock] mM Volume µL [cuvette] mM 
HEPES pH 8.0 at 4oC 200 400 100 
NADPH 5.4 30 0.203 
DHDPR  50  
dH2O  230  
    
Pyruvate 100 20 2.5 
[(S)-ASA] 100 20 2.5 
dH2O  40  
Test solution  10  
Total  800  
 
 
6.3.7 Sodium borohydride inactivation test 
Each enzyme (0.3-1.0 mg/mL) was incubated (30 min, 25oC) with pyruvate (20 mM) or 
(S)-ASA (5 mM) in the presence of Tris.HCl (200 mM, pH 8.0, 4oC). Samples were then 
placed on ice, followed by addition of NaBH4 (25 µL, 100 mM made up with Tris.HCl 
(200 mM, pH 8.0, 4oC) for a total period of 15 min. After that, the samples were placed 
on ice for a further 30 min and then dialysed against 100 volumes of buffer A overnight. 
The activity of DHDPS after treatment with NaBH4 was assessed using the coupled assay. 
 
6.3.8 Far-UV circular dichroism spectroscopy 
Purified wild-type DHDPS, DHDPS-K161A and DHDPS-K161R, which were all stored 
in 20 mM Tris.HCl (pH 8.0), were first applied to a de-salting column against the assay 
buffer (20 Mm NaPO4, 150 mM NaF, pH 8.0) at 4oC. Final concentrations of the proteins 
were determined using a NanoDrop (Thermo Fischer Scientific) reading at A280 to be 
~0.3 mg/mL. CD spectra were recorded from 200 nm to 250 nm at 0.5 nm increments, 
using a 1 mm path length quartz cell. The reported spectra were the average of two scans 
that were corrected for buffer blanks.  
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6.3.9 Differential scanning fluorimetry 
DSF was performed using the iCycler iQ Real Time PCR detection system from Bio-Rad, 
with methods based on those of Niesen et al. (2007).6 Solutions of Sypro orange (20 µL, 
1000x concentrate), protein (80 µL, 0.1-2.0 mg/mL) and pyruvate (5 mM) were added to 
the wells of a 96-well thin-wall PCR plate (Bio-Rad). Water was added instead to protein 
in the control sample and for each well containing pyruvate, there was one without it for 
comparison. The plates were sealed with optical quality sealing tape (Bio-Rad) and 
heated in an iCycler iQ Real Time PCR detection system from 20 to 90oC, in increments 
of 0.30oC. 
 
 
The Boltzmann model (Equation (6.2)) was used to obtain the temperature midpoint for 
each protein unfolding transition, Tm, from the fluorescence data gathered. 
 
Equation (6.2)6 
 
 
Where y is the fluorescence intensity at temperature T, LL and UL are the values of 
minimum and maximum intensities, respectively, and a denotes the slope of the curve 
within Tm.7 
 
6.3.10 Isothermal titration calorimetry 
ITC experiments were performed using a VP-ITC calorimeter (MicroCal, Inc.) as 
described previously.8 All experiments were conducted at 25oC. Purified wild-type 
DHDPS, DHDPS-K161A and DHDPS-K161R, which were all stored in 20 mM Tris.HCl 
(pH 8.0), were first applied to a de-salting column against the assay buffer (20 mM 
HEPES, pH 8.0) at 4oC. Final concentrations of DHDPS-K161A and DHDPS-K161R in 
20 mM HEPES were determined using a NanoDrop (Thermo Fischer Scientific) reading 
at A280 to be 0.3 mg/mL and 0.4 mg/mL respectively. A portion of the buffer was used to 
make up the pyruvate solutions to minimise the heats of dilution. The concentration of 
pyruvate in the syringe used in the DHDPS-K161A experiment was 0.9 µM and 1.4 µM 
( )
a
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for DHDPS-K161R. Prior to titration, all the solutions were degassed under vacuum for 5 
min at 23°C.  
 
The titration schedule consisted of an initial injection of 2 µL, followed by 55 
consecutive injections of 5 µL of pyruvate solution over a period of 10 sec into the 
reaction cell (volume = 1.5 mL), at an interval of 210 s to allow heat equilibration, using 
a syringe rotating at 307 rpm. The initial injection of 2 µL for all samples and third 
injection of 5 µL for DHDPS-K161R were excluded from attempted data fitting due to 
anomalous values. 
 
Efforts to increase the heat generated per injection of pyruvate into DHDPS-K161A and 
K161R were not attempted due to consideration of the heat generated for the binding of 
pyruvate to wild-type DHDPS at similar protein concentrations. 
 
6.3.11 1H NMR spectroscopy 
Deuterated phosphate buffer (Na3PO4, 20 mM, pD 8.16) was prepared via the addition of 
Na2HPO4 (66.2 mg) and NaH2PO4 (4.1 mg) to 5 mL of 99.9% D2O. Conversion of pH to 
pD values was done using Equation (6.3). 
 
Equation (6.3)   pD= 0.929 pH* + 0.42 
 
Where pH* is a direct reading in a D2O solution of the H2O-calibrated pH-meter.9 
An internal standard solution of t-butanol was prepared by diluting t-butanol (8 µL) into 
D2O (200 µL). Pyruvate solution (20 mM) was prepared immediately prior to spectra 
acquisition by dissolving the desired amount of sodium pyruvate in the deuterated 
phosphate buffer (Na3PO4, 20 mM, pD 8.16). 
 
 Experimental samples for data acquisition were prepared via the addition to a 5 mm 
NMR tube of t-butanol standard solution (10 µL), aqueous protein solution (10 µL) and 
sodium pyruvate (20 mM, 400 µL) in deuterated phosphate buffer solution. The tube was 
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inverted a number of times to facilitate mixing and spectra acquisition commenced 
immediately. 
 
The experiment was repeated for several enzyme concentrations. Data recording runs 
were conducted either discretely or continuously. Discrete collection was performed on 
three replicates, with spectra recorded at 1 hour time intervals for the first 6 hours, and 
subsequently at extended intervals for a period of 4 days. Continuous collection was done 
as a single arrayed experiment for a period of 16 hours, acquiring spectra every 10 
minutes to generate 78 unique data points. Proton-deuterium exchange of the enolisation 
of pyruvate α-protons was quantified by comparison of the integral values of pyruvate 
peak area relative to the t-butanol standard. 
 
6.3.12 Crystallisation 
Crystallisation and X-ray data collection 
The crystals were grown at 12oC using the hanging drop-vapour diffusion method as 
described by Mirwaldt et al. (1995).10 The crystal trays were set up as it is described in 
Table 6.9. 
 
The reservoir contained K2HPO4 buffer (1 mL, 1.8 M, pH 10.0). The crystals appeared 
after 2 days and they were soaked in a cryoprotectant solution (K2HPO4, 1.8 M, pH 10.0, 
20% glycerol (v/v)) prior to being flash-frozen in liquid nitrogen when data was required. 
Some crystals were also grown in the presence of pyruvate (20 mM), which was added to 
the buffer solution. Diffraction data sets were processed and scaled using the programme 
CrystalClear.11  
 
Structure determination and refinement 
The structure of each mutant enzyme was solved using MolRep,12 The wild-type enzyme 
structure found in the RCB Protein Data Bank, entry 1YXC, was used to get the 
preliminary structures. Further refinements were done using REFMAC5.12 Electron 
density maps were interpreted with the aid of COOT. Structure quality was assessed 
using PROCHECK13 and other validation tools in COOT.14 
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Table 6.9 Crystal tray set-up for crystallography experiments. 
 
  
Column 
1 
Column 
2 
Column 
3 
Column 
4 
Column 
5 
Protein (µL) 3 3 3 3 3 
Buffer (µL) 1.2 1.1 1 0.9 0.8 
N-OG (µL) 0.45 0.45 0.45 0.45 0.45 
H2O (µL)   0.1 0.2 0.3 0.4 
 
 
Row 1 
Total volume (µL) 4.65 4.65 4.65 4.65 4.65 
Protein (µL) 2.25 2.25 2.25 2.25 2.25 
Buffer (µL) 1.2 1.1 1 0.9 0.8 
N-OG (µL) 0.45 0.45 0.45 0.45 0.45 
H2O (µL) 0.25 0.35 0.45 0.55 0.65 
 
 
Row 2 
Total volume (µL) 4.15 4.15 4.15 4.15 4.15 
Protein (µL) 1.5 1.5 1.5 1.5 1.5 
Buffer (µL) 1.2 1.1 1 0.9 0.8 
N-OG (µL) 0.45 0.45 0.45 0.45 0.45 
H2O (µL) 0.5 0.6 0.7 0.8 0.9 
 
 
Row 3 
Total volume (µL) 3.65 3.65 3.65 3.65 3.65 
 
Where the protein concentration was ~7.5 mg/mL 
 The buffer used was K2HPO4 (1.8 M, pH 10.0) 
N-OG was used at a concentration of 6% (w/v). 
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